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Abstract 
LincRNAs are molecules transcribed from regions with no protein coding 
function, which may have regulatory functions specifically over nearby proteins. 
These ncRNAs are often expressed during early development and may exert 
their regulatory function in a number of ways; either as decoys, guides, 
scaffolds or enhancers. Linc_meis1 and Linc_Onecut1 are LincRNAs located 
adjacent to two well-studied proteins Meis1 and Onecut1, these are the focus of 
the project and were studied using a range of techniques in an effort to 
elucidate their expression patterns and potential regulatory function. These 
particular LincRNAs are suspected of having Cis-regulatory function over their 
neighbouring proteins, this assumption was made because the proteins and 
LincRNAs appear to be co-expressed. Analysis using whole mount in situ 
hybridisations attempted to visualise the native expression patterns of each 
LincRNA within a zebrafish model, however so far this has not been successful. 
Anti sense oligonucleotide morpholino knockdowns were utilised to try and 
determine the importance of each LincRNA for adjacent protein expression and 
study any generated phenotypes. So far the data has been inconsistent and is 
therefore still continuing. A better understanding of these RNA molecules may 
help towards an improved understanding of developmental disorders and future 
development of treatments. 
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LIST OF ABBREVIATIONS  
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1 Introduction  
1.1 Non-coding RNAs 
Until recently the most well studied and important sequences of the genome 
were considered to be the protein coding genes. It is now apparent that these 
make up only 2% of the human genome, the other 98% consisting of non-
protein coding transcripts (Esteller, 2011). Huge interest has emerged over the 
possible functional roles for these other transcripts. Over years it has become 
increasingly obvious that this non-protein coding portion of the genome has 
important roles in both normal development and physiology as well as in 
disease (Esteller, 2011). Non-coding RNAs (ncRNAs) have become popular for 
study in research due their potential functional relevance; discovery of these 
transcripts and realisation that they might have a number of different regulatory 
roles led to a frenzy of research attempting to identify the functions of these 
transcripts and therefore divide them into classes (Esteller, 2011. Rinn & 
Chang, 2012). A non-coding RNA is an RNA molecule that is not translated into 
protein. NcRNAs belong to several groups and are involved in a number of 
different cellular processes. This allows some separation into classes (Guttman 
et al, 2011). 
MicroRNAs (miRNAs) are the class of ncRNAs that are most widely studied, 
epigenetic and genetic defects within this class and their mechanisms of action 
have been attributed to many diseases (Esteller, 2011). These are encoded in a 
huge range of tissues and have multiple functions; of these functions it is 
important to note their ability to target mRNAs to different locations and regulate 
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gene expression levels (Esteller, 2011). A good example is the miR-200 family 
of miRNAs, this group of miRNAs are highly expressed in epithelial cells and it 
has been suggested they contribute to cancer metastasis by inhibiting 
epithelial-mesenchymal transition (EMT). This process is a crucial step in 
eventual metastasis and involved in the spread of cancers (Esteller, 2011). 
Generally this class of ncRNA acts through post-transcriptional regulation of 
mRNA. As an example of how widespread these non-protein coding transcripts 
can be, miR-200 family members have been found in association with bladder, 
breast, ovarian, pancreatic, prostate, stomach and lung cancers (Esteller, 
2011). 
MiRNAs are however just one class of ncRNAs that have emerged, other 
classes such as long non-coding RNAs (LncRNAs) and large intergenic RNAs 
(LincRNAs) also appear to play important roles in normal development and in 
disease. Evidence suggests that ncRNAs can be involved in a range of different 
disorders, such as neurological, cardiovascular, autoimmune, imprinting and 
monogenic disorders (Rinn & Chang, 2011. Wapinski & Chang, 2011). 
Many ncRNAs are conserved over all or most cellular life. These are considered 
to be remnants from LUCA (last universal common ancestor) or the RNA world 
(Mercer et al, 2009. Wang & Chang, 2011). Unlike protein-coding genes it is not 
as necessary for the transcripts of ncRNAs to maintain sequence conservation, 
rather the locations of ncRNA transcripts are highly conserved coupled with 
short sections of highly conserved sequences (Rinn & Chang, 2012). 
NcRNAs are associated with the propagation and progression of many human 
disorders, it is therefore important to develop an understanding of how ncRNAs 
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are involved in pathological effects and the mechanisms by which they act. 
There are a number of different genomic, epigenomic and bioinformatics 
approaches used to help achieve this (Rinn & Chang, 2012). The ENCODE 
project (an Encyclopaedia of DNA elements) is a collaboration of multiple 
research groups which aims to identify all the functional elements within the 
genome (Rinn & Chang, 2012). Other methods aimed at studying ncRNA 
functions are based on and utilise second-generation sequencing (RNA seq); 
these methods provide more detailed observations about the whole human 
RNA transcriptome (Rinn & Chang, 2012). These methods however can run into 
complications when trying to interpret ncRNA complex secondary structures; 
additional algorithms have been designed to complement second-generation 
sequencing (RNAfold, RNAalifold, EvoFold etc.) (Rinn & Chang, 2012). Even 
with these additional algorithms there have only been a few ncRNAs identified 
with this method. The issues with identification are based in a lack of complete 
understanding of the ncRNAs functional motifs and domains, their low 
expression levels and a general need for better characterisation of regulatory 
regions (Rinn & Chang, 2012).  
1.2 Long Non-coding RNAs 
Long non-coding RNAs (LncRNAs) are a class of ncRNA that appear to 
resemble mRNA, however they do not behave as templates for protein 
synthesis (Rinn & Chang, 2012). Rather these function as RNA genes that 
coordinate and manage genetic regulatory outputs. Evidence suggests that they 
are at least partially involved in a number of different cellular processes such 
as; imprinting (an epigenetic process involving DNA methylation and histone 
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modifications which results in silencing of an imprinted gene and expression of 
a certain gene from only the non-imprinted allele inherited from the mother), 
pluripotency, cell cycle regulation, diseases and many more (Rinn & Chang, 
2012. Guttman et al., 2011. Hung et al., 2011). LncRNAs have been implicated 
in post transcriptional gene regulation through control of processes such as 
protein synthesis, RNA maturation, RNA transport and gene silencing through 
regulation of chromatin structure (Khalil et al, 2009). 
It has been suggested that LncRNAs are involved in a number of different 
diseases; both developmental and cancerous (Calin et al, 2007. Scaruffi, 2011). 
Their potential role as regulators of protein function means that the scope of 
their effect could be enormous. The use of DNA microarrays in studying 
ncRNAs has indicated that there are at least as many LncRNA transcripts as 
those encoding proteins (Rinn & Chang, 2012). So far these ncRNAs have 
been characterised by their lack of protein coding function and their size. 
Typically these ncRNAs are considered to be transcripts longer than 200 
nucleotides in length (Rinn & Chang, 2012). However a number of different 
roles for these RNA transcripts have been put forward (Mercer et al, 2009). 
LncRNAs can act through a range of different mechanisms, which have been 
called “Archetypes” (Wang & Chang, 2011).  
Firstly LncRNAs may act as decoys; in this instance the ncRNA serves by 
titrating away DNA binding proteins such as transcription factors to prevent 
activation or repression of its target gene (Figure 1A) (Rinn & Chang, 2012). A 
good example of the effect is seen with PANDA, an LncRNA that associates 
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with the NF-YA transcription factor and titrates it away thereby preventing its 
transactivation of p53 mediated apoptosis (Rinn & Chang, 2012). 
LncRNAs may also behave as a scaffold; this involves the compilation of two or 
more proteins into a complex or within spatial proximity of one another (Figure 
1B) (Tsai et al, 2010. Rinn & Chang, 2012). This mechanism is seen with the 
LncRNA HOTAIR (encoded in the HOXC cluster), which binds and brings 
together the polycomb repressive complex 2 (PRC2) and the LSD1-CoREST 
complex; this combination of proteins orchestrates H3K27 methylation and 
H3K4me2 demethylation. Amalgamation of these two processes ensures gene 
silencing (Gupta et al, 2010. Yang et al, 2011. Rinn & Chang, 2012). 
The third “archetype” is when LncRNAs act as guides; they recruit proteins 
(such as chromatin modifying enzymes) to DNA, which may occur either 
through a direct interaction with the protein or by RNA interaction with a DNA 
binding protein (Figure 1C) (Rinn & Chang, 2012). LncRNAs involved in 
imprinting are often called guides, in that they result in targeted gene silencing 
in an allele specific manner (Rinn & Chang, 2012). HOTAIR can also be 
considered an example for this mechanism as well; it guides PRC2 to the 
correct location at multiple sites throughout the genome in development and 
cancer related gene expression (Gupta et al, 2010. Yang et al, 2011). These 
LncRNAs utilise two basic molecular functions to achieve their regulatory 
function, the binding of protein partners and localisation specific points within 
the genome (Rinn & Chang, 2012). 
The final LncRNA mechanism is an enhancer-like function. LncRNAs are able 
to exert guidance through chromosome looping (Figure 1D) (Rinn & Chang, 
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2012). A great example of this mechanism is the HOTTIP LncRNA, which is 
encoded on the 5’ end of a HOXA gene cluster and through chromosomal 
looping is brought into spatial proximity of multiple HOXA genes where it 
maintains H3K4me3 and gene activation (Rinn & Chang, 2012). 
 
 
Figure 1. Roles of LncRNAs (Taken from Rinn & Chang, 2012) A) Decoys. 
B) Scaffold. C) Guides. D) Enhancers. 
In order to study LncRNAs experimentally it is important to examine their native 
expression patterns and identify specific cell types or cellular processes 
associated with the candidate LncRNA. LncRNAs show cell type specific 
expression and respond to diverse stimuli. A method called “guilt by 
association” has been used to help develop a global understanding of LncRNAs 
and protein-coding genes that are co-expressed (Rinn & Chang, 2012). While 
not necessarily always the case, this tight co-expression often suggests that the 
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two genes are co-regulated. This means the adjacent LncRNA may in some 
way control the expression of the protein via one of the mechanisms mentioned 
above (Rinn & Chang, 2012). The ability of LncRNAs to regulate associated 
protein function might result in diseases such as cancer. Evidence suggests 
that altered expression patterns for LncRNAs in human cancers are seen in 
relation to those controlled through tumour suppressor pathways (Calin et al, 
2007. Esteller, 2011. Wapinski & Chang, 2011). A recent study has identified 
that numerous LncRNAs are either up or down regulated within different 
cancers (Tsai et al, 2011. Yang et al, 2011). An example given in this study 
shows that HOTAIR (encoded in the HOXC cluster) was highly indicative of 
breast cancer metastasis. High levels of HOTAIR expression is associated with 
a poor prognosis and death; this observation has been found in colon and liver 
cancers as well which suggests that elevated HOTAIR LncRNA might be an 
oncogenic trait (Yang et al, 2011. Rinn & Chang, 2012). Other examples of 
LncRNAs, which have been shown to affect the expression of adjacent proteins 
include HOTTIP, a LncRNA located on the HOXA locus and is involved in 
regulating a number of HOXA associated genes. In addition it binds to WDR5 
protein, which forms part of a complex involved in methylation and activation of 
the HOXA locus (Wang et al, 2011). H19 is another LncRNA, which is 
implicated in a number of cancers but has no known protein coding function 
(Brannan et al, 1990). Another good example of a LncRNA is Xist, which has 
been shown to regulate the process of X inactivation in early development of 
mammalian females (Chow et al, 2005). 
  14 
1.3 LincRNAs 
LincRNAs are a subgroup of LncRNAs that originate from intergenic regions 
(the spaces between protein coding genes) that have separate transcriptional 
units from the protein-coding genes, which they may regulate (Ulitsky et al, 
2011. Rinn & Chang, 2012). These LincRNAs typically have highly conserved 
promoter regions which are involved in the recruitment and binding of 
transcription factors to adjacent proteins (Ulitsky et al, 2011). For LincRNAs the 
majority of sequence conservation is found over the introns and intergenic 
regions (Ulitsky et al, 2011). However syntenic LincRNAs found in different 
species can maintain similar functionality despite a difference in sequence 
(Ulitsky et al, 2011). The literature suggests that at least a third of the known 
LincRNAs interact with and utilise chromatin modification complexes to regulate 
a range of cellular processes (Khalil et al, 2009. Rinn & Chang, 2012). 
A study that utilised numerous annotation sources and combined them with 
RNAseq was able to show in excess of 8,000 LincRNAs within the human 
genome (Rinn & Chang, 2012). This helped to identify a number of 
characteristics common in LincRNAs. Such ncRNAs have a propensity for 
location near developmental regulators and appear to maintain tissue-specific 
expression patterns (Rinn & Chang, 2012). Thousands of orthologous 
LincRNAs have been found between mice and humans and the transcript is 
often found in “gene deserts” which are megabase-sized genomic segments 
which lack any protein-coding genes associated with vertebrate genomes (Rinn 
& Chang, 2012). 
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The complexity of LincRNAs makes them difficult to study effectively and hard 
to develop inhibitors that will allow study of the regulatory effects of these 
ncRNAs. Techniques such as SELEX (systematic evolution of ligands by 
exponential enrichment) have been used to identify sequences of RNA that will 
bind to the LincRNAs (Rinn & Chang, 2012). 
Targeting splice sites or conserved regions with antisense reagents may result 
in developmental defects allowing effective study of their regulatory roles, this 
form of study may also elucidate the cell types within which the LincRNA 
resides and exerts its influence and help to demonstrate the importance of 
LincRNAs during embryonic development (Corey & Abrams, 2001. Guttman et 
al, 2011). 
1.4 Meis1 
The Meis1 protein is a member of a homeodomain subfamily of cofactors that 
regulate the activity of Hox proteins (Azcoitia et al, 2005). It has been shown 
that overexpression of Hox proteins leads to an increased population of 
haemopoietic stem cells (HSC) (Azcoitia et al, 2005). Hox proteins are involved 
in hematopoietic system pathologies or in normal hematopoietic development 
and as such the Meis1 protein can be considered a regulator or at least 
involved in the regulation of haematopoiesis. Interactions between Meis1 (and 
other Meis family members) and Hox proteins results in an increased DNA 
affinity and target specificity; these traits are necessary if correct transcriptional 
regulation of Hox targets is to be achieved. Meis1 proteins role in 
haematopoiesis has largely been suggested because of its localisation; this 
protein can be found within adult bone marrow and the HSC compartment of 
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fetal livers (Azcoitia et al, 2005). During the early stages of embryogenesis, 
Meis1 expression can be seen in paraxial, intermediate, and lateral plate 
mesoderm (Azcoitia et al, 2005). During organogenesis, Meis1 is involved in the 
development of a number of organs and embryonic structures, such as early 
eye formation and limb development (Azcoitia et al, 2005). Overexpression of 
this protein has been shown to contribute to the development of leukaemias in 
cooperation with a number of Hox proteins (Azcoitia et al, 2005). Meis1 may 
also have a role in the development of HSCs, it was shown using Meis1 
deficient mice (which died mid-gestation) that the protein is involved in the 
genesis of the first HSC because when lacking Meis1 haematopoiesis fails to 
occur (Azcoitia et al, 2005). The Meis1 protein may also be involved in later 
development and differentiation of vascular networks. 
1.5 Onecut1 
The Onecut1 protein (or Hepatocyte Nuclear Factor 6 –HNF6) belongs to a 
family of transcription factors called ONECUT. This protein is involved in 
regulating the hepatocyte specific transcription, which is necessary for normal 
adult liver function and the development of the hepatic biliary tree and 
hepatocytes from hepatoblasts (Clotman et al, 2002). Onecut1 protein is also 
known to be expressed in the pancreatic duct epithelium during development; 
when inhibited, normal duct growth was prevented (Zhang et al, 2009). Further 
study into this protein revealed that it regulates a network of genes responsible 
for cilium development and hereditary polycystic disease (Pierreux et al, 2006. 
Zhang et al, 2009). A more recent paper shows that this protein has roles in the 
activation of pro-endocrine transcription factor Ngn3 and that early Onecut1 
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inactivation resulted in pancreatic defects (Jacquemin et al, 2000. Zhang et al, 
2009). Onecut1 has both early and late roles in the developing pancreas. A 
more recent discovery is this proteins (and other ONECUT family members) 
involvement in the development of the nervous system; expression of Onecut1 
has been observed in spinal motor neurons during chick development (Francius 
& Clotman, 2010). Expression of the protein is conserved in spinal motor 
neurons and is involved in differentiation during the later stages of motor neuron 
development (Francius & Clotman, 2010). This family of transcription factors 
typically has a C-terminal DNA binding motif, which is comprised of a single 
Cut-domain and a homeodomain (Clotman et al, 2002). 
1.6 Meis1 and Onecut1 LincRNAs 
These LincRNAs are located in the intergenic regions adjacent to the proteins 
Meis1 and Onecut1; they were chosen for study because they appear to be co-
expressed with the adjacent proteins and therefore may be co-regulated (work 
done by Swaraj Basu). So far neither of these LincRNAs has been studied 
before and that means there is a lack of functional data for each. Also, while 
both the associated proteins have been studied quite extensively and therefore 
have known sites of tissue specific expression, the same cannot be said for the 
LincRNAs. Based upon the co-expression and potential regulation a theory has 
been developed; suggesting that they function as Cis-regulatory elements (a 
region of DNA or RNA that regulates the expression of genes located on the 
same molecule of DNA) which are typically located upstream from the coding 
sequence which they control or interact with. The exact mechanism by which 
these two LincRNAs may act upon their nearby protein counterparts is 
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unknown; they may act through any of the mechanisms described in section 1.2 
or perhaps through another mechanisms which remains un-described. 
Different stages of development will be used to demonstrate the tissue 
specificity of the LincRNAs and show that they are only expressed at certain 
stages, when required. The Meis1 protein and LincRNA are separated by 1155 
base pairs; the Onecut1 protein and LincRNA are separated by 332 base pairs. 
Figure 2 below shows a snapshot of the genome browser displaying the 
distance between each LincRNA and the adjacent protein. 
 
Figure 2. Snapshot from the Genome Browser displaying distance 
between LincRNAs and adjacent proteins. 
Figures 3 and 4 demonstrate the co-expression seen between each LincRNA 
and its adjacent protein. These graphs show expression patterns across early 
development within zebrafish models; they were generated using RNAseq data. 
Morpholinos will be used to knock down the LincRNA and then examine 
changes in morphology. Both of the proteins have been previously studied and 
therefore phenotypes are available to demonstrate the effect of knockdowns. 
This can be used to compare with LincRNA knockdowns, if the same effect is 
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observed it would suggest a regulatory function. Following this experiment it 
would be interesting to know if LincRNA knockdown causes overexpression or a 
lack of expression of the adjacent proteins. This could indicate whether it is 
positively or negatively regulating the protein. This LincRNAs were picked for 
study based upon previous work by Swaraj Basu; he determined that Meis1/ 
Onecut1 and their LincRNAs are syntenic in mammals and fish. Also the CAGE 
data showed that they share a similar expression profile in zebrafish; with 
similar peaks visible at sites of promoters/ over the length of each transcript. 
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Figure 3: RNAseq expression pattern across early developmental stages 
in zebrafish for the meis1 gene and its upstream LincRNA (Taken from a 
presentation by Swaraj Basu). 
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Figure 4: RNAseq expression pattern across early developmental stages 
in zebrafish for the onecut1 gene and its upstream LincRNA (Taken from a 
presentation by Swaraj Basu). 
 
 
 
1.7 Zebrafish Model 
Zebrafish are a vertebrate model system that is regularly used in scientific 
research because it has many advantages and shares 70% of human protein 
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coding genes and 84% of disease associated genes (D’Costa & Shepherd, 
2009). Firstly, the genome has been fully sequenced. In combination with well-
understood and easily observable behaviours these models provide a great 
platform to study gene expression and alteration. In addition, Zebrafish lay large 
numbers of transparent embryos in a controlled and predictable manner. These 
enable the study of embryonic development because they grow in well-defined 
embryonic stages over short periods of time. The development from fertilisation 
to hatching takes 48 hours. The Zebrafish can then develop to sexual maturity 
over the following 3 months and live up to 5 years. Also, they maintain a near 
constant size during early development, which enables the use of simple 
staining techniques such as Whole-Mount In Situ Hybridisations. Genetic 
studies commonly use Zebrafish models where knocked down gene expression 
is achieved using either small-interfering RNAs or antisense Morpholino 
technologies (White et al, 2007; D’Costa & Shepherd, 2009; Bradford et al, 
2011). 
 
 
1.8 Methodology Crucial to the Project 
1.8.1 PCR 
Polymerase chain reaction, a biochemical technology used in molecular 
research to amplify single or multiple strands of DNA by large orders of 
magnitude. Millions of copies of the DNA strand of interest can be generated in 
a relatively short time (Ochman et al, 1988). This technique has a number of 
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different applications such as DNA cloning for use in sequencing, functional 
analysis of genes and diagnosis of some hereditary diseases (Cold Spring 
Harbor Laboratory, 2003). The process involves varying temperatures over a 
number of cycles; the repeated heating and cooling of DNA allows for 
replication and enzymatic activity. Short DNA sequences (primers) that are 
complimentary to stretch of DNA being amplified are used in combination with 
DNA polymerase to enable the selective replication. A few cycles into the 
process the DNA so far generated is then used as a template resulting in 
exponential amplification through a chain reaction (Cold Spring Harbor 
Laboratory, 2003). These cycles can be broken down into a few steps; first 
comes initialisation where the reaction mixture is heated to a high temperature 
to activate the DNA polymerase. Following this a short cycle where DNA is 
heated to a high temperature to allow unwinding of the DNA double helix 
occurs, this is called denaturation (Chantler, 2004). The annealing step is at a 
lower temperature and allows the primers to bind to their complementary 
sections of DNA. Finally there’s the elongation step in which the polymerase 
synthesises a new stretch of DNA; the temperature for this step is dependent on 
the type of polymerase being used (Chantler, 2004). This process is then 
coupled with agarose gel electrophoresis to check whether the anticipated DNA 
fragment was successfully made (when compared against a DNA ladder of 
known size). This technique will be useful in generating the probe and can be 
used to confirm expression of genes of interest (when coupled with agarose gel 
electrophoresis). 
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1.8.2 Whole-Mount In Situ Hybridisation 
This process uses a labeled complementary RNA strand as a probe, which 
hybridises at a target location on a specific sequence of DNA or within a specific 
tissue; this type of in situ in particular relies on small tissues and hybridisation 
can occur over the entire tissue (Darnell, 2010). The process means 
researchers can measure and detect the localisation of specific RNAs. During 
this experiment the sample tissues are usually fixed in place, this increases the 
access for the probe during hybridisation (Darnell, 2010). The probe hybridises 
to the target location at a high temperature, following which the excess probe is 
washed away. The probe had been previously labeled with antigen-labeled 
bases (Darnell, 2010); which means that immunohistochemistry could be used 
to detect expression and allow quantification and localisation (this works for 
both native expression and over expression studies, and can be used to confirm 
successful knockdown experiments in theory). The study of expression patterns 
is important because it gives an indication of functionality. This pattern can be 
either within a specific cell type or a specific cellular process (Darnell, 2010). 
With meis1 and onecut1 there is previous data regarding the proteins, which 
each LincRNA is adjacent to, and therefore a good starting point for 
understanding their potential role. This process of using gene expression 
analyses to study adjacent protein-coding genes and pathways that significantly 
correlate with the LincRNAs is often called “guilt by association” studies. It 
would be useful to combine WISH with morpholino knockdowns to determine if 
the antisense oligos successfully silenced expression of the target. 
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1.8.3 Morpholino Knockdowns 
A morpholino is a molecule used in research that can alter gene expression; 
they bind to specific sequences of DNA and prevent other molecules from 
accessing the same stretch or prevent transcription of certain genes (Corey & 
Abrams, 2001). This technique can be utilised in research to study functional 
aspects of proteins and ncRNAs by knocking down said functions (Corey & 
Abrams, 2001). The mechanism has been called “steric blocking”. These 
molecules are often used in developmental research to study the roles of 
specific transcripts; this is achieved by injecting embryos at a very early stage 
with a solution containing these synthetic oligos (Corey & Abrams, 2001. 
Langenau & Zon, 2005). Binding to their complementary sequence should 
prevent proper development of the protein or transcript and have adverse 
effects on the embryos development. 
 
Figure 5: Morpholino methodology (taken and modified from Langenau 
and Zon, 2005). 
This image simply outlines how morpholinos are used in research. 
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Gene knockdown studies enable the establishment of the importance of each 
LincRNA in the developmental process. Following successful identification of 
the LincRNAs for Meis1 and Onecut1 using WISH, it would be useful to knock 
them down and determine whether expression of the associated proteins still 
occurs. 
1.9 Aims and Objectives 
The aim of this project was to study the LincRNAs adjacent to Meis1 and 
Onecut1 proteins and their potential regulatory role during early development. If 
possible the experiments were meant to help elucidate the functions of each 
LincRNA and determine their expression patterns. The main objectives of the 
project were to develop an anti-sense probe using PCR from total genomic DNA 
for each of the LincRNAs. Following probe design, Whole-mount in situ 
hybridisations would be utilised to study where the LincRNAs were being 
expressed and if possible to what level. And after that morpholino knockdowns 
would reveal any regulatory function of the LincRNA by development of new 
phenotypes in embryos following injection. If possible, identification of the 
nature of said LincRNA functions as either positive or negative regulators of 
proteins could be achieved using loss of function analyses and over expression 
studies. 
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2 Materials and Methods 
2.1 Buffers and Solutions 
Buffer Ingredients 
5x Buffer 20mM Tris-HCl (pH 7.5 at 25°C), 0.2M NaCl, 0.1mM EDTA, 1mM 
DTT, 0.01% Nonidet® P-40 and 50% glycerol 
Elution Buffer 10 mM Tris-HCl; pH 8.5 
Hybridisation Mix 5x SSC, 0.1% Tween, pH 6 with Citric Acid (Monohydrate), 50 μg/ml 
heparin, 500 μg/ml torula RNA and 50% Formamide 
NTMT staining buffer 100 mM NaCl, 100 mM Tris-HCl, 50 mM MgCl2, 0.1% Tween 20; pH 
9.5 
NTMT staining solution 100 mM NaCl, 100 mM Tris-HCl, 50 mM MgCl2, 0.1% Tween 20, 
1.88 mg/ml NBT, 0.94 mg/ml BCIP; pH 9.5 
PBS 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4 
PBS EDTA PBS pH 5.5/2mM EDTA 
PBT 0.1M PBS, 0.5% Tween 20, pH 7.4 
PCR Buffer 1.5 mM MgCl2 
PFA 4g Paraformaldehyde in 100 ml PBS 
PTU 0.003% 1-phenyl-2-thiourea 
RNA-Loading Buffer 47.5% Formamide,   0.01% SDS,   0.01% bromophenol blue, 
  0.005% Xylene Cyanol,   0.5mM EDTA 
SSC 3M NaCl, 0.3M sodium citrate (for 20X concentration) 
TE Buffer 10 mM Tris-HCl, 1 mM EDTA, pH 8.0 
 
2.2 Plasmids 
Vector Insert 
pCS2+ Linc_Meis1 Exon 1/ Linc_OC1 
 
2.3 Antibodies 
Number Antibody Type of Antibody Brand 
1 In Situ Hybridization Goat Monoclonal Anti-Digoxygenin Roche 
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2.4 Zebrafish Husbandry 
Wild type Tubingen zebrafish strains were used for all the experiments. These 
were kept at 28oC in an incubator within the laboratory. When required, a 
number of breeding tanks (roughly 10) were set up in the fish facility the 
evening before embryo collection. Dividers and separators are used to keep the 
male (1 per tank) and females (2 per tank) apart until the next morning. Upon 
removal of the dividers the fish will lay and embryos can be collected. This are 
transferred to petri dishes with standard embryo media for transportation to the 
lab. If developmental stages beyond 24 hours of development were required, 
PTU was added to the embryo media to suppress pigmentation. 
2.5 Morpholino Injections 
The antisense Morpholino oligonucleotides that we used to knockdown the 
LncRNAs were purchased from GENE TOOLS, LLC in the US. The 
Morpholinos targeted specific locations for each LncRNA; for linc_onecut1 a 
conserved transcript initiation site was chosen, and for linc_meis1 a splice 
junction site. The Morpholinos stock solutions were combined with nuclease 
free water and phenol red. Then using glass micropipettes and a microinjector 
setup, 4nl of each Morpholino solution was injected into embryos at the one to 
two cell stage of development. 
 
Antisense MO sequences (5’→3’). 
Morpholino linc_onecut1 GCTGAAAGGGAATCAGTATGCAAAT 
5 mispair oligo for linc_onecut1 GCTcAAAcGGAATgAcTATGgAAAT 
Morpholino linc_meis1 AGCGACTTAGAGAGAGAAAGATTCA 
5 mispair oligo for linc_meis1 AGCcAgTTAcAGAGAcAAAcATTCA 
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2.6 Isolation of total RNA 
Total RNA was isolated using the TRIZOL® reagent made by Invitrogen in the 
US. 1ml of TRIZOL® reagent for every 50-100 mg of tissue sample was used to 
homogenise the samples; these were taken from 24hpf. The samples were then 
incubated for 5 min at room temperature. Chloroform was added to each of the 
tissue samples 0.2ml for every 1ml of TRIZOL®. The samples were then 
shaken vigorously for 15 seconds by hand; following this the tissue samples 
were left to incubate at room temperature for 3 minutes. The phases were 
separated by centrifugation (12000xg; 15 minutes; at room temperature). The 
upper aqueous phase formed after centrifugation was transferred to a fresh 
tube Eppendorf tube and precipitated with 0.5 ml of isopropyl alcohol per every 
1 ml of TRIZOL®. Further centrifugation (12000xg, 10 minutes, at 4°C) was 
used to collect the RNA which was subsequently washed with 1 ml of 70% 
ethanol for every 1 ml TRIZOL®. After this wash step, the RNA pellet was dried 
for 10 minutes by upending the Eppendorf tube and allowing to air dry. This 
pellet was then solubilised in RNase-free water, the concentration calculated 
using a nanodrop and then stored at -80°C. 
2.7 Isolation of genomic DNA from embryos 
Embryos were collected and allowed to develop to 3dpf; these were then used 
to isolate genomic DNA. Upon reaching the right developmental stage the 
embryos were washed in Methanol (which dehydrates them), this was followed 
by drying for 15 minutes at 70°C in an incubator. Following this, the embryos 
were treated for 4 hours with an enzyme called Proteinase K (0.5 mg/ml), which 
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was diluted to its working concentration using TE buffer (see section 2.1). The 
embryos were incubated with the enzyme at 55°C. After this digestion the 
enzyme was inactivated by a shorter incubation at 75°C. Subsequently the 
mixture of digested embryos and enzyme was diluted using nuclease free water 
at a ratio of 1:2.5 and stored at -20°C. 
2.8 Agarose gel electrophoresis of DNA and RNA 
Agarose gel electrophoresis was used to separate DNA and RNA fragments. 
Due to differences in molecular weight, this method allows isolation of specific 
bands of nucleotides, which travel at different rates through the gel. The DNA 
and RNA fragments were run on a 1% agarose gel which contained ethidium 
bromide, this allowed visualisation of both DNA and RNA fragments. RNA was 
loaded into the wells with an RNA-loading buffer. 
2.9 Isolation of DNA from agarose gels 
A 1% agarose gel with ethidium bromide was used to visualise PCR products 
and DNA fragments; this could then be placed under a UV-light. This allowed 
easy visualisation of the DNA bands, which were then carefully cut out using a 
scalpel. Following this extraction from the gel the DNA had to be separated from 
the remaining agarose gel; this was achieved using the NucleoSpin® Gel and 
PCR Clean-up kit from Macherey Nagel in Germany. The section of cut gel was 
incubated at 50°C with the kits provided NT1 binding buffer (200 μl of buffer for 
every 100 mg of gel) until the gel had fully melted. The resultant sample was 
transferred to a filter column and spun in a centrifuge (11000xg, for 1 minute, at 
room temperature). After centrifugation the column was washed twice with 750 
μl of NT3 washing buffer for 30 seconds each time with a spin in the centrifuge 
  31 
after each wash (11000xg). The DNA that was now bound to the column and 
had most impurities washed away was eluted with 50 μl of elution buffer (see 
section 2.1) and stored at -20°C. 
2.10 Reverse Transcription 
An M-MLV Reverse Transcriptase and RNase H Minus kit from Promega in the 
US was used to induce production of cDNA from RNA. This reaction used 100 
ng of total RNA (isolated in section 2.6), which was incubated with 5.0 μl of 5x 
Buffer at room temperature, 5.0 μl of dNTP Mix (10 mM concentration of each 
dNTP), 1 μM Oligo-dT primer and 2.0 μl of M-MLV Reverse Transcriptase, 
Rnase H Minus (M-MLV RT). The total reaction volume was 20 μl, nuclease 
free water was used to make up the final volume. The reaction mixture was then 
incubated for 1 hour at 37°C. Following incubation the mixture was kept at -
20°C. 
2.11 Polymerase Chain Reaction 
When performing PCR each of the reaction mixtures contained: 100 ng of 
template DNA, 200 μM dNTPs, 1 μM forward primer, 1 μM reverse primer, 2 
units AmpliTaq® DNA-Polymerase from Roche in Switzerland and PCR Buffer 
(section 2.1) were incubated together in a thermocycler for 30 cycles with 
alternating temperatures. During the first cycle the reaction mix was denatured 
at 95°C for 5 min. After initial denaturation the samples were denatured at 95°C 
for 30 sec, primers were allowed to anneal at 55°C for 30 sec and DNA 
synthesis was carried out at 72°C for 45 sec; this occurred 30 times. This was 
followed by a final elongation step at 72°C for 10 min. The reaction mix was 
then cooled down to 4°C and further processed. 
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PCR primers (5'-3') 
linc_meis1 Exon1 FP  GCTATAAGAGGCTTTAAACAAAAAC 
linc_meis1 Exon1 RP  CGACAAACGCGTGCGTGTTTATC 
linc_meis1 Long FP  GCTATAAGAGGCTTTAAACAAAAAC 
linc_meis1 Long RP TGTCAAAAGGGAAAGCTGACAAA 
linc_meis1 Short FP  TTACTATCAAATCCCCAAAGC 
linc_meis1 Short RP  TTTGTGTGTTGATTTAAAATTTATTC 
linc_onecut1 FP  TAATTTGCATACTGATTCCCTTTCAGC  
linc_onecut1 RP  GTATTTAAACATTTTCTTTATTTTCAGAAAATC 
 
2.12 Enzymatic digestion of DNA 
3 μl of pCS2+ plasmid DNA was incubated at 37°C for 2 hours in a 50 μl 
reaction. 1 μl of restriction digestion enzyme and 5 μl of corresponding buffer 
purchased from New England Biolabs in the US. The total volume of this digest 
was adjusted using nuclease free water. 
2.13 Ligation of PCR-product with the pCS2+ plasmid vector 
The PCR reaction mix was column purified for each LincRNA. In the case of 
linc_meis1 exon1 the band was cut from a gel and purified to reduce the 
number of breakdown products. The PCR products were then ligated with a 
pCS2+ vector, which had been previously digested using Stul enzyme. This 
ligation was achieved using an In-Fusion® HD Cloning Kit from Clonetech in the 
US. According to the manufacturers instructions: 4 μl of the PCR product were 
incubated with 2 μl of 5X In-Fusion HD Enzyme Premix and 2 μl of Vector. 
Using nuclease free water the volume was increased to a 10 μl total volume. 
This reaction mixture was then incubated at 50°C for 15 minutes. Half of the 
ligation reaction was used for transformation into competent E. coli DH5α cells. 
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2.14 Transformation of bacteria with DNA 
Competent E. coli DH5α cells were transformed with vector or DNA-ligation 
reactions; the vector only acted as a control. 50 μl aliquots of DH5α cells were 
thawed on ice and mixed with either 5 μl of plasmid DNA or DNA-ligation 
reaction. The mixtures were then incubated on ice for 30 minutes. Following this 
incubation the cells were heat-shocked for 45 sec at 42°C. The resultant cell 
suspension was mixed with 500 μl of Luria-Bertani (LB) medium and incubated 
at 37°C for 1 hour. After incubation the DH5α cells (which now contain either 
the control plasmid vector DNA or DNA-ligation reaction samples) were plated 
onto LB-ampicillin agar plates (Ampicillin at 0.1 mg/ml concentration) and 
incubated overnight at 37°C. The formation of colonies indicated that the DNA-
ligation reaction had been successful. Formation of colonies on the control 
plates was not desirable. 
2.15 Isolation of plasmid DNA from bacteria 
10 Eppendorf tubes each containing 1 ml of LB medium were inoculated with a 
single colony of E. coli DH5α picked from a LB-ampicillin agar plate (these were 
labeled 1-10). These LB cultures were grown overnight at 37°C with vigorous 
shaking. After allowing sufficient growth overnight, the cells were collected by 
spinning in a centrifuge (14000xg; for 5 minutes; at room temperature). Using a 
QIAprep® Miniprep kit from Qiagen in the US, plasmid DNA was isolated. The 
manufacturers instructions are as follows: The pelleted bacterial cells were 
resuspended in 250 μl of Buffer P1 and transferred to a fresh microcentrifuge 
tube. 250 μl of Buffer P2 was added to the centrifuge tube and mixed 
thoroughly by inverting 4–6 times. Following this, 350 μl of Buffer N3 was added 
  34 
and again the tubes were inverted immediately to thoroughly mix the solution. 
After addition of each of the buffers the solution was centrifuged for 10 minutes 
at 13,000 rpm (~17,900xg). Following centrifugation the supernatant was 
transferred to a QIAprep spin column by pipetting, this spin column was then 
centrifuged for 30–60 seconds. The flow-through was discarded and the spin 
column was washed by addition of 0.5 ml of PB buffer followed by a 30 second 
spin, and then washed with 0.7 ml of PE buffer and spun again. After these 
washes the spin column was placed into a fresh 1.5 ml microcentrifuge tube. 
DNA was eluted using 50 μl of Buffer EB; this was left to soak into the 
membrane within the column for 1 minute followed by a 1 minute spin in the 
centrifuge. 
2.16 In-vitro transcription of digoxigenin-labeled RNA 
Digoxigenin (DIG)-labeled probes for in situ hybridisation (ISH) were generated 
using the DIG labeling kit made by Roche in Switzerland. 2 μg of linearised 
template plasmid-DNA (EcoRV digested) was incubated with 4μl 5X 
transcription buffer, 2μl NTP-DIG-RNA, 2μl T7 Polymerase and 1.5 μl RNase 
inhibitor. The total volume was increased to 20 μl with nuclease free water and 
the mixture was incubated for 2 hours at 37°C. In order to purify the RNA, any 
remaining template DNA had to be removed by adding 20 U DNase I and 
incubating the solution at 37°C for 15 min. The RNA was purified with GE 
Illustra™ MicroSpin™ G-25 Columns as per the manufacturers instructions: The 
resin in the column was resuspended by vortexing. The cap was loosened by 
one-quarter turn and the bottom closure twisted off. The column was placed in 
the supplied collection tube followed by a 1 minute centrifugation (735 ×g). It 
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was placed into a fresh DNase-free 1.5 ml microcentrifuge tube and the Dig 
labeled RNA was added to the top-centre of now prepared resin. The column 
was then centrifuged for 2 minutes at 735×g then the eluate collected, the 
concentration measured using a nanodrop and stored at -20 °C. 
2.17 Whole-mount In Situ Hybridisation 
2.17.1 Embryo Fixation 
Zebrafish embryos were collected and allowed to develop to stages at which 
the LncRNAs of interest are reportedly expressed. These were then 
dechorionated and fixed overnight in 4% PFA in PBS. Following fixation, PBS 
was used to wash the embryos and 100% methanol was added to them. This 
dehydrated the embryos and meant they could be stored at -20°C. 
2.17.2 Day 1 of In Situs 
Using serial dilutions the embryos were rehydrated. A range of methanol 
solutions in PBT were used to wash the embryos in Eppendorf tubes (75%, 
50% and 25% methanol). Following rehydration the embryos were washed 4 
times in PBT for 5 minutes each at room temperature. This was followed by a 
digest with proteinase K (10 μg/ml) in PBT (15 min for embryos over 24 hpf and 
30 min for 32-72 hpf embryos) at room temperature (this step, subsequent 
fixation and washes are not necessary in embryos younger than 24 hpf). The 
digest was stopped by washing 2 times with PBT for 5 minutes at room 
temperature. Following digestion with proteinase K the embryos were fixed in 
4% PFA in PBS for 20 minutes at room temperature and washed 4 times for 5 
minutes with PBT at room temperature. Hybridisation buffer (Hyb Mix or HM) 
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was added to each of the embryos, which were then left to sink to the bottom. 
Fresh hybridisation buffer was added and the embryos were left to incubate at 
68°C for 2 hours. After the stipulated time the embryos were incubated 
overnight at 68°C with the DIG-labeled RNA probe (1 μg/ml concentration) in 
fresh hybridisation buffer. 
2.17.3 Day 2 of In Situs 
Following the overnight hybridisation with a probe (the probe was carefully 
recovered and stored at -20°C for re-use) the embryos were washed with a 
number of different solutions: 50% HM/50% 2XSSC at 68°C for 5 minutes, 
2XSSC at 68°C for 15 minutes, 0.2XSSC at 68°C for 30 minutes, twice; 50% 
0.2XSSC/50% PBT at room temperature for 10 minutes and finally with PBT at 
room temperature for 10 minutes. Fresh PBT/2% goat (or sheep) serum/2mg:ml 
BSA was prepared and the embryos were incubated in this blocking solution at 
room temperature for several hours. The embryos were then incubated in 
antibody solution overnight at 4°C (PBT/2% goat serum/2mg:ml BSA/1:2500 
anti-DIG antibody). 
2.17.4 Day 3 of In Situs 
Unbound anti-DIG antibody was washed off the following day by washing the 
embryos multiple times at room temperature in PBT (1 X 1 min, 3 X 5 min, 4 X 
15 min). Following the washes, embryos were then incubated 2 times for 5 
minutes each in NTMT staining buffer (section 2.1) at room temperature and 
then in NTMT staining solution (section 2.1). The staining reaction was stopped 
by removing the staining solution and washing the embryos for 3 minutes in 
  37 
stop-solution (PBS EDTA, section 2.1). Embryos were fixed with 4% PFA for 20 
minutes at room temperature or longer (it was possible to store the embryos at 
this stage at 4°C). For imaging the embryos were given 3 quick washes with 
methanol followed by serial dilutions of methanol/PBT (75% MeOH, 50% 
MeOH, 25% MeOH, PBT). The final step before imaging was a series of 
washes in serial dilutions of glycerol/PBT (25% glycerol, 50% glycerol, 75% 
glycerol, 100% glycerol). 
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3 Results 
3.1 Amplification and cloning of the LncRNAs 
Using RT-PCR, a 1.2KB cDNA fragment representing linc_onecut1 was 
amplified and cloned; the genetic material (total DNA) used as a template was 
taken from 24 HPF embryos. For linc_meis1, the process was more complex 
due to the presence of two different possible transcripts (one was 2 KB, the 
other 2.4 KB). This was determined using RNAseq and CAGE data and 
therefore two different sets of primers were designed. No RT-PCR product was 
detected for the linc_meis1 transcripts. This may be caused by a low expression 
level in the RNA sample (Figure 6). The exons (Exon1 400 bp, Exon2 2 KB) of 
linc_meis1 long transcript were PCR amplified from zebrafish genomic DNA 
(Figure 7). After successful amplification of both exons, PCR and ligation 
reactions were used to attempt to fuse each fragment together and into the 
PCS2+ plasmid. This was ultimately unsuccessful, yielding no positive colonies. 
Consequently the 400 bp fragment of linc_meis1 was amplified alone and 
cloned with a PCS2+ plasmid. Anti-sense RNA probes were prepared with T7 
RNA polymerase, for the full-length linc_onecut1 transcript and the 400 bp 
fragment of linc_meis1 (Figure 8). 
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Figure 6. Agarose gel: PCR amplification of linc_meis1 and linc_onecut1 from 
24 HPF whole embryo RNA. Meis1 LS : lincMeis1 Long primer specific, Meis1 
SS: lincMeis1 Short primer specific, Onecut1 S: lincOnecut1  primer specific, 
Meis1 LO : lincMeis1 Long primer reverse with Oligo dt, Meis1 SO: lincMeis1 
Short primer reverse with Oligo dt, Onecut1 SO: lncOnecut1 primer reverse with 
Oligo dt. 
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Figure 7. Agarose gel: PCR amplification of exons of linc_meis1 from genomic 
DNA. LincM1E1: 400 bp first exon. LincM1E2: 2 KB second exon. 
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Figure 8. Agarose gel: RNA probe prepared for ISH. LincM1E1: probe from 1st 
exon of linc_meis1, lincOC1: probe from full-length linc_onecut1 transcript. 
3.2 Whole-mount in situ hybridisation 
So far, attempted detection of expression patterns has been unsuccessful with 
LncRNAs simply showing non-specific background staining; the reason remains 
unclear. The hybridisation protocol was repeated using a low temperature (4 
°C) slow staining which again failed to show a specific binding of the probes 
(Figure 9, 10, 11). Specific staining was visible for the probe against the 
neurogenin1 coding gene (positive control) in the diencephalon, tegmentum and 
hindbrain at 24 hours post fertilisation in zebrafish embryos (Figure 11). Due to 
the non-specific background staining seen in each of the attempts using a 
standard in situ protocol, a number of small alterations were made upon 
repeats. More washes with PBT on day 3, no dehydration after embryo fixation 
and slow staining. An image was taken for each of the different methods and 
can be seen below (Figure 12). Discussion about the different protocols and 
lack of positive results can be found in section 4. 
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Figure 9. ISH: Whole mount in situ hybridisation of zebrafish embryos with the 
linc_onecut1 antisense probe across early developmental stages A) 15 somites 
B) Prim 5 C) Prim 15. 
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Figure 10. ISH: Whole mount in situ hybridisation of zebrafish embryos with the 
linc_meis1 exon1 antisense probe across early developmental stages A) 15 
somites B) Prim 5 C) Prim 15. 
 
 
Figure 11. ISH: Whole mount in situ hybridisation of zebrafish embryos with the 
neurogenin1 antisense probe across early developmental stages A) 15 somites 
B) Prim 5. 
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Figure 12. Images of repeats showing non-specific background staining. 
A) 15 somites, linc_OC1 probe, slow staining/ extra washes B) 24 hpf, 
linc_OC1 probe, slow staining/ extra washes C) 15 somites, linc_meis1 probe, 
slow staining/ extra washes D) 24 hpf, linc_meis1 probe, slow staining/ extra 
washes. 
3.3 Antisense morpholino oligonucleotide based knock-down 
In an attempt to determine the optimum concentration initial injections were 
performed using concentrations of 50, 100 and 150 μM for both linc_onecut1 
and linc_meis1 antisense morpholinos. Observable effects were seen at 
different concentrations for each morpholino; however despite the difference 
neither has yielded consistent results. At 50 μM concentration there were no 
signs of toxicity, non-specific cell death, or lethality. For each dose, 
approximately 100 embryos were injected and then scored at 24hpf and 48hpf 
for normal and abnormal phenotypes. 5-base mispairing morpholinos in which 
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five of the 25 residues are altered to prevent binding to the target were used as 
controls. This checks that the morpholino itself is not mistargeting other 
transcripts or causes toxicity. The mispairing morpholinos did not cause any 
gross phenotypes or developmental delay with any concentration. A smaller 
head phenotype was observed with the linc_onecut1 morpholinos at 150 μM 
concentration at 48hpf (Figure 13). A greater number of abnormal fish were 
observed when injected with the linc_onecut1 morpholino by comparison to the 
5mm morpholino (Figure 15A, 15B) The linc_meis1 morpholino injected fish 
showed non-specific cell death and necrosis at 24 hpf and increased mortality 
at 48 hpf. Following these results the concentrations were reduced to 100 μM 
for each morpholino; this however resulted in a lack of specific phenotype for 
the linc_onecut1 morpholino. The fish for linc_meis1 morpholino showed a 
delay in growth and cell-death in the notochord (Figure 14). The linc_meis1 
morpholino and its corresponding 5mm control show a better resolve between 
the number of normal and morphant embryos at this concentration (Figure 15C, 
15D). It was observed that a high percentage of the linc_meis1 morpholino 
injected fish showed almost no movement at 48hpf at all tested concentrations. 
The embryos were considered dead when no visible heartbeat was observed 
and therefore not counted. Figure 16 shows the percentage survival of embryos 
after injection with morpholinos at two different concentrations. Clearly the 
higher concentrations resulted in the death of more embryos even in the 5mm 
controls. A desirable concentration has yet to be established. 
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Figure 13. Morpholino injections at 150 μM: linc_onecut1 antisense 
oligonucleotide and its 5 base pair mis-match A) 5mm phenotype at 1dpf B) MO 
phenotype at 1dpf C) 5mm phenotype at 2dpf D)  MO phenotype at 2dpf. 
 
Figure 14. Morpholino injections at 100 μM: linc_meis1 antisense 
oligonucleotide and its 5 base pair mis-match A) 5mm phenotype at 1dpf B) MO 
phenotype at 1dpf C) 5mm phenotype at 2dpf D) MO phenotype at 2dpf. 
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Figure 15. Morpholino injection statistics: A) 24 HPF, MO concentration of 
100 μM B) 48 HPF, MO concentration of 100 μM C) 24 HPF, MO concentration 
of 150 μM D) 48 HPF, MO concentration of 150 μM. 
 
 
Figure 16. Morpholino injection statistics: A) MO concentration of 100 μM B) 
MO concentration of 150 μM. 
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4 Discussion 
The purpose of the investigation was to study the LincRNAs adjacent to two 
previously well-studied proteins called Meis1 and Onecut1. This project involved 
the use of a number of different experiments, which combined aimed to 
elucidate the expression patterns of the LincRNAs and perhaps gain an insight 
into their functionality and mechanisms of actions. PCR was used in order to 
develop an anti-sense RNA probe from total RNA of 24hpf zebrafish for each of 
the LincRNAs. Anti-sense RNA probes were prepared with T7 RNA 
polymerase, for the full-length linc_onecut1 transcript and from a 400 bp 
fragment of linc_meis1 corresponding to the first exon. A probe for each of the 
LincRNAs was successfully prepared, along with a control probe (Neurogenin) 
with a known expression pattern to prove the probes were correctly made 
(Figures 8, 11). These probes were then used in whole-mount in situ 
hybridisations (WISH). This method is regularly used to visualise the expression 
patterns of proteins and RNA in zebrafish models. Other vertebrate models 
such as mice may be used, however the rapid and external development 
coupled with transparent embryos enables researchers to study developmental 
diseases quickly and effectively. The in situ hybridisations carried out over the 
course of this project have so far been unable to show a native expression 
pattern for either of the LincRNAs. An example of the Neurogenin probe in 
zebrafish has been provided to show successful application of the WISH 
protocol (Figure 11). So far the results have simply shown non-specific 
background staining in the zebrafish models that appears pink all over the fish 
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(Figures 9, 10); a clear expression pattern would appear a dark purple or blue 
colour in a specific location or tissue. The protocol was repeated a number of 
times, with various changes made to the process to try and develop a set of 
steps sensitive enough to show the expression of these lowly expressed 
LincRNAs. Figure 12 has been added to show a lack of difference between sets 
of results. At the same time we ran anti-sense oligonucleotide morpholino 
knockdowns; this type of “Loss of function” experiment was meant to prevent 
the expression of the LincRNAs within zebrafish models. Injections performed at 
an early stage mean that the synthetic molecule binds to its complementary 
strand within the genome and prevents transcription of the target. A morpholino 
was designed for each LincRNA; the purpose was to study the phenotype 
developed and perhaps illuminate their functions, potential regulatory roles and 
importance to survival. Our results were not consistent with this experiment; the 
effective dosage was difficult to ascertain, with a low dosage showing little or no 
change in phenotype (as compared to a 5mm control) and high dosages often 
causing rapid death in the embryos as well as stunted growth. A phenotype for 
linc_onecut1 was observed with some fish, a smaller head at 48hpf. This result 
was not consistent in all of the fish or in every repeat (performed with a range of 
morpholino concentrations). This suggests that it may have been an artifact of 
morpholino injection. Likewise for the linc_meis1 morpholino injected fish, cell 
death was seen in the notochord for some embryos, but for most the cell death 
was non-specific. This again would suggest there might be an artifact of 
morpholino injection involved in the resulting phenotype. None of the results 
throughout this experiment resulted in significant successes; however there is 
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still much work that needs to be done and a number of extra controls should 
probably be performed to ensure that the techniques were being performed 
correctly. 
Each of the experimental techniques used during this project have strengths 
and weaknesses that are important to discuss. PCR is an essential technique in 
research because it is a simple procedure that is quick to run and requires very 
little starting material in order to generate millions of copies of the desired 
stretch of DNA; this technique is regularly utilised to screen for expression of 
desired fragments of DNA when coupled to agarose gel electrophoresis 
(Chantler, 2004). There are however some drawbacks to the technique; in order 
to amplify the gene of interest prior and detailed knowledge of the DNA 
sequence are required in order to design primers. Also in order to ensure a 
successful result, the process must be optimised by varying the concentrations 
of chemicals involved and the temperatures of each cycle; this is largely 
dependent on the primers (Ochman, 1988. Chantler, 2004). The PCR process 
is limited to a certain size, the maximum regularly achieved is 5kb, however the 
larger the stretch of DNA the less efficient the process. PCR is a highly 
sensitive technique and is therefore susceptible to contamination from non-
template DNA present in the lab (Slish, 2013). This can lead to false results and 
therefore when preparing for PCR the area of work is kept as sterile as 
possible. The polymerases used in PCR often lack 3' to 5' exonuclease activity 
and therefore lack the ability to correct misincorporated nucleotides resulting in 
a higher error rate (Slish, 2013). Taq polymerase is a good example of a DNA 
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polymerase regularly used in PCR that lacks this activity. Some recombinant 
polymerases have been developed in order to increase PCR activity. 
Whole-mount in situ hybridisation was the second technique utilised throughout 
this project and is a standard for detecting RNA presence within embryos. This 
experiment is important because a lot of knowledge can be gained from 
studying gene expression patterns; often genes with developmental regulatory 
function are expressed in a localised manner (Darnell, 2010. Rinn & Chang, 
2012). This type of screening can be used in zebrafish models to identify 
differentially expressed developmental regulators. Anti-sense RNA probes are 
commonly used and are made from transcribed cDNA copy of the target. The 
problem with this is that the correct stretch of cDNA can be hard to come by. 
Digoxygenin (DIG) labeled nucleotides are inserted into the anti-sense RNA 
every 10-15 nucleotides and enable detection via specific antibodies that bind 
to the DIG molecule (Darnell, 2010). While this is an effective method, there are 
a few problems. RNA probes are easily degraded by RNases and generally are 
not very effective if shorter than 300bp in size (Darnell, 2010). 
The final method used during this project is anti-sense oligonucleotide 
morpholino knockdowns. This approach is enables study of gene function in 
vivo, however the results are sometimes considered to be ambiguous (Corey & 
Abrams, 2001). As seen in this project, high levels of cell death were seen in 
morpholino injected embryos, but this may simply be due to the process of 
injection. For this reason a number of controls are required. In this project we 
used 5 mis-match morpholinos as controls. These injected embryos usually 
displayed a wild type phenotype, however we did see cell death on occasion, 
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which shows that simply injecting with a morpholino can alter the normal growth 
of an embryo. The process on the whole is great for study of early embryo 
development, but non-antisense effects may be seen and cause false positives 
when unintended interactions occur between the morpholino and proteins or 
DNA nearby; also the morpholino may bind to other “non-target” sections of 
nucleotides with similar sequences (Corey & Abrams, 2001). 
Based on the results so far it is unclear what role these LincRNAs play in 
regulating the proteins encoded next to each, both the in situ hybridisations and 
the morpholino knockdowns provided inconclusive data. The work is still in 
progress within the lab and still has potential to yield some significant results 
when successful protocols can be developed. The in situ hybridisations could 
not tell us the expression specificity of the long non-coding RNAs. Initial 
morpholino based targeted knock down of the non-coding transcripts yielded 
visible phenotypes, however so far these are not consistent and may be 
artifacts caused by injections. There are a number of things that could be done 
to further work given enough time. To ensure that the right targets are being 
studied, it would be a good idea to check for meis1 and onecut1 expression 
using Northern blots (while RT-PCR is more sensitive, Northern blots are more 
specific and therefore is less likely to get false positive results). If possible it 
would also be good to perform a series of morpholino injections with rescue 
experiments, this could confirm whether the cell death and stunted growth 
observed were simply due to injections or actually an effect of the morpholinos. 
As a control a p53 knockdown morpholino (which has been shown to work 
previously) could be injected simultaneously with the LincRNA morpholinos; if 
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the cell death is prevented then the cell death being observed is a normal p53 
mediated apoptosis and not an effect of LincRNA knockdown. With repeated 
experiments it would hopefully be possible to develop an in situ protocol 
sensitive enough to capture the expression dynamics of the candidate genes. If 
this doesn’t work however, it might be worth performing an over expression 
study of the LincRNAs because their expression is so low. Coupled with ISH 
this could at least allow study of the localisation (this however would not be 
valid alone and would require the native expression pattern at some point). 
Failing that, another probe may have to be designed for each LincRNA if study 
into their regulatory function is to continue. 
These LncRNAs may have regulatory functions over adjacent proteins and as 
such are important to study. Successful study and interpretation of their roles 
may help towards the better understanding of developmental disorders and 
future development of treatments. 
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Abstract 
Hypoxia inducible factors (HIFs) are heterodimeric transcription factors that 
regulate oxygen homeostasis and stress responses, are involved in causing or 
responding to liver disease. The aim of this investigation was to study HIF2α 
stabilisation and activity within hepatocytes after exposure to hypoxia and the 
pro-inflammatory cytokine TNFα. The kinetics of HIF stabilisation were 
determined using a hypoxia responsive element (HRE) luciferase reporter gene 
assay. Exposure to low oxygen stabilised HIFs and stimulated HRE 
transcriptional activity and luciferase reporter gene expression in Huh-7.5 and 
HepG2 cells. HRE transcriptional activity differed under two different hypoxic 
conditions (1% versus 3% oxygen; P<0.05, unpaired t-test). Hypoxic responses 
were compared in DMSO-differentiated and naïve Huh-7.5 cells with no 
significant difference, but a change in activity followed chronic hypoxic 
exposure. Comparing the effects of TNFα on both cell lines indicated no 
significant activation beyond hypoxia alone when plotted relative to normoxic 
controls. However, data obtained with lipopolysaccharide-stimulated 
macrophage conditioned media indicated an increase in activity under hypoxia, 
perhaps suggesting the presence of additional cytokines or factors that regulate 
activity. These kinetic data have not been shown before and contribute to the 
understanding of HIF regulation and identification of potential therapeutic 
targets for liver disease. 
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7 Introduction 
7.1 The Liver 
The liver, which is the largest organ in the body, is located on the right side of 
the abdomen below the diaphragm. A nutrient rich blood supply circulates 
through the liver via the hepatic portal artery, traverses the entire organ through 
sinusoidal capillaries before leaving via the hepatic portal vein. The liver is 
highly specialised with diverse functions including a major role in metabolism, 
toxin removal, and the synthesis and storage of carbohydrates. Consequently, it 
is comprised of numerous cell types (van Leeuwen et al, 1994). The 
hepatocytes, also known as parenchymal cells, comprise 80% of the liver mass 
and perform the majority of liver functions. The remaining 20% of cells, non-
parenchymal cells, includes endothelial, Kupffer, and stellate cells, which have 
several functions, including initiating a response to hepatic injury (Kolios et al, 
2006). A cartoon depiction of the liver architecture is in Figure 1. 
Under normal conditions in an adult healthy liver, hepatocytes do not divide. 
However, under toxic conditions or in a disease state the hepatocytes are able 
to proliferate, a process known as regeneration. This occurs when the liver is 
damaged, but additionally, when occurring in an uncontrolled manner, is 
involved in the development of cancers. It is well known that the liver is able to 
replace up to two thirds of its mass after a liver transplantation; it will grow back 
until the point the organism requires and then proliferation stops (Taub, 2004). 
7.2 Oxygen Range 
Anatomically the liver is divided into three zones, each of which has a different 
protein and carbohydrate profile due in part to variation in oxygen levels; zone 1 
is located near the portal triad, zone 2 is the centrio-lobular region, and zone 3 
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adjoins the hepatic vein (Figure 1) (Adams & Eksteen, 2006). The oxygen 
concentration ranges from 11% to 3% from the portal triad to the hepatic vein, 
respectively. An oxygen level of 3% is considered a hypoxic environment, 
therefore part of a healthy liver is likely to exist under a hypoxic state 
(Jungermann & Kietzmann, 2000). 
 
Figure 1: A cartoon depicting different zones within a liver lobule (Adams 
& Eksteen, 2006). 
Figure 1 represents the anatomy of a section of liver. The numbers indicate 
zones of the liver. From zone 1 to 3 the gradient of oxygenation ranges from 
11% to 3%. 
 
Several liver diseases are associated with hypoxia and the tightly regulated 
host responses to hypoxia. For example, ischemia-reperfusion, obstructive 
sleep apnea, alcoholic liver disease, hepatitis C virus (HCV) infection, and 
hepatocellular carcinoma are all known to contribute to the development of, or 
persist within, a hypoxic environment. All these diseases are associated with 
2 
1 
3 
3 
1 
2 
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activation of hypoxia inducible factor (HIF) responses (Nath & Szabo, 2012). 
When hepatic parenchymal and non-parenchymal cells are exposed to hypoxic 
stress the varying oxygen concentrations induce a variety of effects and can 
determine whether a hepatocyte is capable of responding to the hypoxic stress 
and to what extent. Low oxygen conditions result in increased metabolic 
demand, tissue ischemia, as well as other conditions. These can all contribute 
to liver injury while under hypoxic stress (Broughan et al, 2008). 
7.3 Hypoxia and Diseases of the Liver 
Hypoxia can have a deep impact on the tissues of an aerobic organism. The 
liver has a normal homeostatic response to hypoxic conditions, which may 
become altered while in a diseased state. Normal adaptation to hypoxia results 
in the activation of stress response genes, which usually have beneficial effects, 
improving cell survival or eliminating aberrant cells. Stress responses include 
angiogenesis, erythropoiesis, glycolysis, proliferation, and apoptosis, activities 
regulated through the action of an evolutionarily-conserved family of 
transcription factors called hypoxia inducible factors (HIFs) (Corpechot et al, 
2002; Maegdefrau et al, 2009). A number of diseases associated with the liver 
up regulate HIFs beyond normal levels (Nath & Szabo, 2012). Of most 
importance to the research in this project are the effects of HIFs in viral hepatitis 
and hepatocellular carcinoma (HCC). 
7.3.1 Viral Hepatitis 
There are at least three liver tropic viruses that are responsible for liver 
pathogenesis, hepatitis B, C, and E. Hepatitis B is the major cause of liver 
cancer in China and has been linked to hypoxia and liver damage through the 
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association of hepatitis B virus protein X (HBx) with HIF1α expression (Xie et al, 
2008). The transfection of this protein into HepG2 cells has been shown to 
result in HIF1α accumulation. HBx protein has also been shown to increase 
levels of metastasis associated protein 1 (MTA1) and histone deacetylase 1 
(HDAC1), both of which are involved in HIF1 stabilisation and directly interact 
with the transcription factor (Han et al, 2007). 
Hepatitis E virus is associated with liver disease through the development of 
hepatitis and liver injury. Hepatitis E virus open reading frame 3 protein (ORF3) 
is a viral protein that is thought to be important for infection. This protein has 
been shown to up regulate a number of enzymes involved in the glycolytic 
pathway. In addition, there is an associated up regulation of HIF1α expression 
and stabilisation through phosphorylation of the CBP/p300 co-activator in an 
ERK-dependent manner. This correlates with HIF1α up regulation and 
increased AkT phosphorylation (Moin et al, 2009). 
Chronic HCV infections are a common cause of chronic liver disease and 
cirrhosis. A persistent infection is enabled by the rapid replication of virus 
particles combined with continuous cell-to-cell spread and the lack of a vigorous 
host immune response (Chen & Morgan, 2006). There is a strong association 
between chronic HCV infection and the development of cirrhosis and 
hepatocellular carcinoma (HCC) (Shepard et al, 2005). There are a number of 
mechanisms by which HCV might interact with HIF1α. Stabilisation may be 
mediated by oxidative stress and calcium signalling caused by the expression of 
HCV genes; it has been shown that the NFκB, STAT3, PI3-K/ AkT and p42/44 
mitogen-activated protein kinase pathways are all involved in this stabilisation. It 
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has also been shown that stabilisation of HIF1α through these pathways leads 
to stimulation of VEGF and angiogenesis as well as numerous other stress 
responses, including glycolytic enzyme up regulation (Nasimuzzanan et al, 
2007; Ripoli et al, 2010). An association between HCV core protein and HIF1α 
has been observed in hepatoma cells. The core proteins induced an up 
regulation in VEGF expression and HIF1α DNA binding by EMSA. Transient 
infection with HCV or the presences of HCV subgenomic replicons are both 
linked to HIF1α stabilisation (Nath & Szabo, 2012). 
7.3.2 Hepatocellular Carcinoma 
There is a strong evidence to suggest the involvement of HIFs in the 
development of HCC. HIF associated genes such as the glucose transporter 
GLUT1 and growth factor VEGF have been shown to be up regulated in 
individuals with HCC and these have been implicated in malignant 
transformations. As with viral hepatitis, multiple pathways appear to be involved 
in the development of HCC. PI3K, ERK and NFκB are all associated with HIF 
stabilisation and involved in disease progression (Sun et al, 2009; Daskalow et 
al, 2010; Fu et al, 2011). 
Interestingly, it has been shown that both HIF1α and HIF2α isoforms are up 
regulated in HCC. Up regulated HIF2α is found in 69.5% of HCC cases and 
correlates with tumour size, capsule infiltration, portal vein invasion, and 
necrosis. HIF2α up regulation is also associated with VEGF expression; 
however, there is evidence showing a decreased chance of survival. HIF2α was 
not shown in non-cancerous tissue, suggesting that its expression may be a 
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feature of tumours and their formation (Bangoura et al, 2004; Bangoura et al, 
2007). 
A better understanding of HIF regulation, activity and stabilisation could 
contribute towards future therapies for liver disease by providing targets to 
regulate HIF activity. 
7.3.3 Hypoxia Inducible Factors 
Hypoxia inducible factors (HIFs) are a family of transcription factors involved in 
the host adaptation to low oxygen environments. They are master regulators of 
the homeostatic response to changing oxygen concentrations and are found 
within nearly all cells and tissues. Stabilisation occurs under low oxygen and 
indicates the transcription factors are no longer being actively degraded. There 
are three currently known isoforms of HIF: 1α, 2α, and 3α, and the latter has 
multiple splice variants. HIF1α is expressed ubiquitously within all cells, 
whereas HIF2α and 3α appear to be more tissue-specific; their expression has 
been demonstrated within liver parenchymal cells. These subunits bind to a 
common HIFΒ subunit, also called ARNT, which is continuously expressed and 
not dependent on local oxygen concentration. Hundreds of genes are reportedly 
regulated through the action of hypoxia and HIFs; these genes are activated in 
response to stress (Bertout et al, 2008; Kaelin & Ratcliffe, 2008). 
A number of genes reported to be HIF targets may only be responsive to HIFs 
within a small range of tissue types, with activation dependent on interaction 
with other cooperative molecules. There is evidence to suggest that different 
isoforms of HIF alpha subunit may be differentially regulated by multiple 
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mechanisms and that each subunit is capable of stimulating expression of 
distinct genes within the same environment, or activating the same genes with 
different observed effects (Majmundar et al, 2010). 
7.3.4 HIF1α 
HIF1α, the alpha subunit of a heterodimer called HIF1, is involved in glucose 
metabolism, regulation of lipid metabolism, liver injury and tumour-associated 
angiogenesis, metastasis and inflammation. It is responsible for converting 
metabolism from oxygen-dependent ATP production to glycolysis under low 
oxygen conditions through the promotion of glycolytic enzyme activity and 
LDHA expression. Combined, these actions provide additional NAD+ required 
for glycolysis under hypoxia. Also, HIF1α promotes the expression of its target 
gene PDK1, which prevents the conversion of pyruvate into acetyl-CoA and 
reduces the oxygen consumption within cells. HIF1α has also demonstrated 
activity in converting glycolytic intermediates into RNA or DNA through the 
pentose phosphate pathway. These metabolic changes are part of an important 
role in facilitating cell survival and growth under low oxygen conditions (Simon, 
2006; Gordon et al, 2007). 
HIF1α is involved in the angiogenic response to low oxygen. The dimer binds to 
promoter regions within the target gene VEGF, enhancing expression of this 
growth factor. This effect has been observed in a number of injury models such 
as myocardial infarction, skin wound healing, and hepatic injury (Heinl-Green et 
al, 2005; Mace et al, 2007; Sano et al, 2007; Botusan et al, 2008; Liu et al, 
2008). It is noteworthy that it is also responsible for stimulating angiogenesis 
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within tumours in a similar manner. However, the surrounding environment is 
filled with different cell types such as fibroblasts, which might respond differently 
to the hypoxic stress and contribute differently to the stress response (Jain, 
2005; Du et al, 2008). Whether these responses require HIF stabilisation under 
hypoxic or normoxic conditions is currently unclear (Bertout et al, 2008; Kaelin, 
2008). It has been suggested that HIF1α has a role in the regulation of cancer 
metabolism in certain tissues. Mutations that cause inactivation of the enzymes 
fumerate hydratase (FH) and succinate dehydrogenase (SDH), both involved in 
the TCA cycle, result in increased levels of HIF1α stabilisation within tumours 
through increased ROS activity inhibiting the prolyl hydroxylases (PHDs) after 
accumulation of fumerate and succinate (King et al, 2006). 
HIF1α also has a role in cancer metastasis and invasion. The expression of 
HIF1α can contribute to the loss of E-cadherin. The mechanism of action differs 
between types of cancers; however, the evidence is clear that HIF1α 
expression is involved in epithelial to mesenchymal transition (EMT). In head 
and neck squamous cancers this transcription factor directly regulates TWIST1 
transcription, which is responsible for tumour cell invasiveness and metastasis. 
HIF1α can also produce a similar response in prostate cancer through up 
regulation of SNAIL1 via VEGF (Kaelin, 2008; Yang et al, 2008; Mak et al, 
2010). 
HIF1α is also involved in inflammation. An inflammatory response to hypoxic 
stress is linked to the NFκB pathway within macrophages and neutrophils. 
NFκB activation alone is insufficient to stabilise HIF1α; rather, the additional 
regulation through exposure to low oxygen is required. This suggests the 
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possibility of graduated HIF stabilisation within hypoxic stress environments 
(Rius et al, 2008).  
HIF1α, which represents a potential target for therapy in a large number of liver 
associated diseases, have been studied in macrophages, renal cells and 
hepatocytes, among others, under both hypoxia and normoxia. The McKeating 
lab is interested in HIFs because it has been shown that HCV virus is capable 
of stabilising the HIF1α protein under normoxic conditions (Nasimuzzamann et 
al, 2007; Ripoli et al, 2010), suggesting that this transcription factor has 
beneficial effects on the viral lifecycle. 
 
 
Figure 2: HCV stabilises HIF1α (Wilson et al, 2012) 
Figure 2 presents a confocal image displaying the stabilisation of HIF1α in cells 
infected with HCV using GFP. 
7.3.5 HIF2α 
Much like HIF1α, HIF2α is important for regulating stress response genes in an 
oxygen-dependent manner. HIF2α has only recently been investigated and 
while there are currently no studies showing the stabilisation or activity of HIF2α 
within the liver, it appears the target genes activated by HIF1α and HIF2α 
overlap, suggesting they have similar roles or perhaps that they complement 
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one another (Kim et al, 2006; Keith et al, 2012). In contrast, other studies 
suggest that they oppose one another, having opposite effects on several 
different genes. However, there is evidence to suggest that the gene silencing 
of one isotype results in the over expression of the other (Pan et al, 2004; Fang 
et al, 2009; Majmundar et al, 2012). Could this be a compensation mechanism? 
When considering potential therapeutic targets for cancers, HIF1α is probably 
not the end of the story. 
Similar to HIF1α, HIF2α is a subunit part of the HIF2 heterodimer involved in the 
regulation of stress response genes and has diverse roles in regulating stress 
response pathways, including glucose and lipid metabolism, angiogenesis, 
inflammation, and redox homeostasis. HIF2α has also been implicated in 
tumour associated angiogenesis and tumorigenesis (Majmundar et al, 2012). 
Both HIF1α and HIF2α are able to alter the expression of cytochrome C oxidase 
in order to increase the efficiency of the electron transport chain. However, 
HIF2α has some unique roles in the regulation of redox homeostasis. It is 
responsible for up regulation of an anti-oxidant enzyme called SOD2, which 
regulates aberrant ROS accumulation. The loss of HIF2α activity contributes 
towards the accumulation of ROS and ultimately leads to associated activation 
of p53 and tumour cell death (Scortegagna et al, 2003; Gordan et al, 2007). 
HIF2α has been associated with lipid catabolism, although little is known about 
its involvement at present. Similarly, HIF2α has a role in angiogenesis, but in 
comparison with HIF1α it has not been extensively studied its role is yet to be 
elucidated. However, it has been shown that it can stimulate the production of 
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functional blood vessels in endothelial cells, which has implications in tumour 
progression (Beroukhim et al, 2009; Morris et al, 2009; Dalgliesh et al, 2010). 
Unlike HIF1α, the presence of HIF2α within a tumour microenvironment is 
indicative of a poor prognosis, suggesting opposite roles within the 
development of tumours. In renal carcinoma cells the selective inhibition of one 
or both of the HIF isoforms showed that HIF2α is essential for tumour 
progression whereas HIF1α is not (Leek et al, 2002; Kawanaka et al, 2008) 
possibly related to their differential interaction with the transcription factor MYC. 
MYC is responsible for controlling the G1/S stage of the cell cycle and 
promoting proliferation through induction of most glycolytic enzymes and 
enhanced protein synthesis. HIF1α has been shown as an antagonist of MYC 
whereas HIF2α promotes this activity (Gordon et al, 2007a; Mylonis et al, 2006; 
To et al, 2006; Kalousi et al, 2010). Other observations suggest that the 
aberrant activity of HIF2α may be more oncogenic than HIF1α.  
HIF2α is also activated through the action of pro-inflammatory cytokines and the 
NFκB pathway. However, the responsible cytokines differ between HIF2α and 
HIF1α. This differential activity warrants further investigation because there is 
evidence suggesting a correlation between tumour associated macrophages 
(TAMs) in breast cancers and poor prognosis. It has also been shown that the 
deletion of HIF2α in mice with HCC prevented migration of TAMs into the 
tumour environments. HIF2α has roles in the stimulated migration or 
chemotaxis of macrophages (Leek et al, 2002; Murdoch et al, 2004; Kawanaka 
et al, 2008).  
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7.3.6 HIF3α 
The third isoform of HIFs is the least studied within the family. However, a 
recent paper has observed that the protein undergoes polyubiquitination and 
proteosomal degradation in the same way as the other HIFs. Unlike the other 
two isotypes, HIF3α has a number of different splice variants. So far at least 7 
variants have been identified, which can be separated by size. It has been 
suggested that the long variants are located within the nucleus while under 
hypoxia, whereas the short transcripts can be found in the cytoplasm. The 
interaction of HIF3α variants with other HIFs inhibited nuclear translocation. 
None of the HIF3α variants are capable of efficient hypoxia responsive element 
(HRE) activation. However, it was shown that the down regulation of HIF3α 
caused a reduction in some HIF target gene expression (Augstein & Poitz, 
2011. Heikkilä et al, 2011), perhaps indicating that HIF3α is not limited to a 
negative regulatory role over HIFs, but rather is responsible for multiple 
functions in controlling the host cell response to hypoxia. 
HIF3α lacks a transactivating domain, much like an identified negative regulator 
of HIF-1 called IPAS (inhibitory PAS domain protein). IPAS prevents the 
interaction and dimerisation of HIF1α with HIF1β by binding to the HIF1α 
subunit, which prevents the binding to HRE and subsequent activation of any 
pathways. HIF3α might therefore be a negative regulator of HIF pathways 
(Augstein & Poitz, 2011. Heikkilä et al, 2011). Previous experiments studying 
this isoform were conducted in Chinese hamster ovary (ChoK1) cells and most 
studies have shown that HIF3α is expressed abundantly within the kidneys and 
lung epithelial cells. While expression of HIF3 α  has been shown in 
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hepatocytes, there are few studies showing HIF3α  activity in liver cells 
(Augstein & Poitz, 2011. Heikkilä et al, 2011). 
7.3.7 HIF Stabilisation 
Under normoxia HIFs are rapidly degraded, which is important in the regulation 
of activation of certain stress response genes. Figure 3shows the pathway that 
results in proteosomal degradation under normoxia for HIF1α. The other HIF 
isotypes (2α/3α) may be regulated in the same or similar manner. Under 
normoxia, the PHDs hydroxylate HIF1α at two conserved proline residues found 
within the oxygen-dependent degradation domains (ODD) (Carroll & Ashcroft, 
2005). Hydroxylation of these domains results in the recruitment of the Von 
Hippel Lindau protein (VHL) E3 ligase complex, which results in the 
polyubiquitination of HIF1α and subsequent proteosomal degradation (Carroll & 
Ashcroft, 2005). At the same time, factor inhibiting HIF (FIH-1), an asparaginyl 
hydroxylase, interacts with the HIF1α, modifying the protein. This prevents the 
interaction of HIFs with co-activator p300/CBP (Lando et al, 2002). The 
combination of these two activities results in transcriptional inactivation under 
normoxic conditions. 
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Figure 3: HIF1α regulation under hypoxia or normoxia (Carroll & Ashcroft, 
2006) 
Under hypoxic conditions the activities of these two hydroxylases is inhibited, 
which results in the stabilisation of HIF1α, following which, the protein begins to 
accumulate then translocates to the nucleus. After translocation to the nucleus 
the protein dimerises with its HIFβ counterpart. This heterodimer then binds to 
co-activators p300/CBP and this dimer binds to the HREs found within the 
regulatory regions of target genes, stimulating a wide range of stress responses 
(Carroll & Ashcroft, 2005). 
Mitochondria appear to be involved in oxygen sensing, PHD inhibition, and HIF 
stabilisation. Under “moderate” hypoxia (approximately 1.5% oxygen), 
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mitochondria release reactive oxygen species that inhibit the activity of PHDs 
(Kaelin et al, 2005; Klimova & Chandel, 2008). It has been suggested that the 
radicals may originate from electron transport chain complex III directly and that 
mitochondria might be involved in HIF regulation (Klimova & Chandel, 2008). 
This effect may be limited to moderate hypoxic conditions, below which HIFs 
may stabilise in the absence of mitochondria. This pathway may be similar to or 
a part of the pathways described in the section below.  
Environmental oxygen concentration can determine which HIF becomes stable 
and begins to accumulate. Evidence suggests that at oxygen concentrations of 
0-2%, HIF1α is stabilized, and at 2-5%, HIF2α is stabilised (Nilsson et al, 2005; 
Holmquist-Mengelbier et al, 2006; Li et al, 2009). However, studies have shown 
that different factors such as pro-inflammatory cytokines, growth factors and 
bacterial products can contribute to HIF stabilisation even under normoxia 
(Imtiyaz & Simon, 2010) and the majority of pathways involved in stabilisation 
mechanisms are currently not fully understood. Cytokines such as TNFα and IL-
1β, which act through the NFκB pathway, have been shown to induce the 
accumulation of the HIF1α isoform and increase transcriptional activity (Imtiyaz 
& Simon, 2010). Others, such as TGF-β, act through inhibition of PHD2 
expression. These cytokines have roles in inflammation and inducing HIF 
activity, which suggests that HIFs may have a role in inflammation. HIFs may 
also be stabilised through stimulation with bacteria and bacterial products such 
as lipopolysaccharide (LPS). This activity may be linked to a number of 
pathways, including NFκB, ROS, PHD,s and mitogen activated protein kinases 
(MAPKs) (Imtiyaz & Simon, 2010). 
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The pathway most frequently described in HIF stabilisation after oxygen 
regulation is the NFκB pathway. NFκB (nuclear factor κB) is a transcription 
factor found within most cell types and involved in pathways stimulated by 
stress responses, cytokines, ROS, and bacterial or viral antigens. This pathway 
is predominantly regulated through the activity of IκB (inhibitor of κB) proteins, 
which sequester NFκB dimers within the cytoplasm. These proteins inhibit 
activity by masking the nuclear localisation signal (NLS) of NFκB proteins. IκB 
proteins activity is inhibited through the activity of enzymes IKK (IκB kinases), 
which utilise phosphorylation of IκB to target the protein for degradation (van 
Uden et al, 2008). This activation of NFκB has been reported to contribute to 
basal levels of HIF1α mRNA and proteins through mediation of the subunit 
expression and stabilisation as well as promoter activity (Görlach & Bonello, 
2008). Various factors such as TNFα, bacterial products such as LPS, and 
reactive oxygen species have been shown to stabilise HIF1α via the NFκB 
pathway by phosphorylating IκB; NFκB binds to a conserved region within the 
promoter of the HIF1α gene (Imtiyaz & Simon, 2010). In turn, activation of this 
pathway and subsequent HIF1α stabilisation regulate the production of 
numerous cytokines and multiple stress response pathways. 
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Figure 4: Cartoon depicting HIF1α stabilization through NFκB activation 
(Görlach & Bonello, 2008). 
Figure 4 represents two pathways involved in HIF1α stabilisation. It illustrates 
how both hypoxia and cooperative factors thrombin, TNFα, and H2O2 stabilise 
the transcription factor and result in subsequent stress response activation. 
 
The activation of Toll-like receptors (TLR) by exposure to pathogens and their 
products (such as LPS) is also associated with disease pathogenesis and HIF 
stabilisation (Imtiyaz & Simon, 2010). A number of previous reports indicate that 
HIF protein accumulation is increased by PHD2 and PHD3 inhibition in a TLR4 
dependent manner under normoxia (Uesugi et al, 2001; Scharte et al, 2006; 
Peyssonnaux et al, 2007; Jantsch et al, 2011). There is evidence to suggest 
that HIF also binds directly to TLR4 and up regulates TLR4 expression while 
under hypoxia, which in turn increases HIF stabilisation and subsequent 
cytokine/chemokine production. This interaction suggests the presence of a 
positive feedback loop resulting in increased HIF responses under hypoxia and 
during infection (Kim et al, 2009). 
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Figure 5: Cartoon depicting HIF stabilisation through TLR4 signalling 
(Imtiyaz & Simon, 2010) 
Figure 5 represents the TLR4 pathway of HIF stabilisation and the various 
factors associated with receptor activation.  
TLR (toll-like receptor), MyD88 (myeloid differentiation primary response gene 
88), LPS (lipopolysaccharide), PHDs (prolyl hydroxylases), MAPKs (mitogen 
activated protein kinases), ROS (reactive oxygen species), NFκB (nuclear factor 
κB). 
 
7.4 Aims and Objectives 
The main aim of the project was to study the role of HIFs in HCV biology and 
liver injury. This project is part of a larger whole in which HCV utilisation of HIFs 
as part of the viral lifecycle is being studied. The work within this thesis is not a 
complete project, but rather part of an ongoing study. 
The objectives were to study the kinetics of HIF stabilisation and transcriptional 
activity in hepatoma cells at varying oxygen concentrations and to investigate 
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the role of TNFα in stabilising HIF-transcriptional activity in hepatoma cells. In a 
broader view, it is of interest to investigate the role of HIF2α within the liver and 
adaptation to stress, whether HIF1α and HIF2α regulate the same genes in 
hepatocytes and are they regulated in the same way, and what benefits might 
this confer on the virus lifecycle or tumour microenvironments. 
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8 Materials and Methods 
8.1 Plasmids 
Vector Insert 
pGEX-4T 
pCDNA 
HRE Luciferase 
NFκB Luciferase 
 
8.2 Cell Lines 
Name Tissue Growth Media Source 
Huh-7.5 Human Hepatoma DMEM Jhaveri Laboratory at 
Duke University 
HepG2-CD81 Human Hepatoblastoma DMEM Prepared in the 
McKeating Laboratory 
 
8.3 Tissue Culture 
Huh7.5 cells and HepG2 cells were obtained from Charles Rice (Rockefellar 
University, New York and the American Tissue Culture Collection. Cells were 
maintained in Dulbecco’s modified Eagles medium (DMEM) (Gibco, USA) 
supplemented with 10% foetal bovine serum (FBS), 1% v/v penicillin-
streptomycin (pen/strep) and 1% L-Glutamine. For normoxic experiments cells 
were incubated at 37oC with 20% O2 and 5% CO2. For hypoxia cells were 
grown under 1 or 3% oxygen in a humidified sealed hypoxystation (Don Whitely 
Scientific, UK) calibrated to 5% CO2 and 95% N2.  
8.4 Transfections  
Cells prepared 24 hours prior to the transfection stage had been grown in 
DMEM with 10%FBS. The incubations during this growth period were all at 
37oC in 20% O2 and 5% CO2. Before transfection began the media in each well 
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of the plate was replaced with pen/strep free DMEM with 3%FBS. Transfections 
were carried out using Lipofectamine 2000 (Invitrogen) according to the 
manufacturers instructions. The cells were transfected with a pGEM plasmid 
(Margaret Ashcroft, UCL, London). The DNA/ lipofectamine mixture is then 
added drop wise to the cells and incubated at 37oC/ 5% CO2 for 6-8 hours. 
Following this incubation period the DNA is carefully removed and the media 
replaced with DMEM containing 3% FBS and pen/strep. The cells are left 
overnight in the incubator before experimentation. 
8.5 HRE Luciferase Assay 
This assay is performed to ascertain the kinetics of HRE activation in cells 
exposed to hypoxic conditions representing HIF activity. Following transfection, 
the cells were split into 96 well plates for each time point and condition using 
standard tissue culture techniques. The contents of each well is then combined 
within a universal and 100ul added to appropriate wells of a 96 well plate for 
5,10, 15 and 25 hour time points. The cells are then treated with the appropriate 
concentrations of pro-inflammatory cytokines (TNFa) or 10% DMEM (control) 
and then placed into either normoxic (20% O2) or hypoxic (1-3% O2) 
incubation. A T0 time point is taken at this point. The media is removed from 
each well in the 96 well plate. 50ul of 1x luciferase lysis buffer is added to each 
well. At appropriate times, the other plates are removed from their condition, the 
media removed and luciferase lysis buffer added. After the full 25 hours of the 
time course have passed the plates are removed from the freezer and left to 
thaw for a couple of hours. The luciferase assay substrate is also removed from 
the freezer and allowed to thaw (the contents is light sensitive and therefore 
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kept wrapped in foil). The 50ul of lysis buffer and lysed cells is transferred to the 
96 well luminometer plates. 50ul of luciferase assay substrate is added to each 
well. The plate is then read using a luminometer. The kinetic setting is chosen 
and each well is read for 5 seconds per well. 
8.6 LDH Assay 
At the desired time points 50ul of supernatant from each sample was 
transferred to a 96 well plate (round bottomed ELISA plates). The positive 
controls are cell lysates prepared using freeze thaw lysis (15 minutes in -80oC, 
15 minutes in 37oC, repeat). 50ul of positive control lysate is added to the same 
96 well plate. Add 50ul of the substrate mix (Promega) to the supernatants and 
cell lysates. The plate is covered in foil and left to incubate at room temperature 
for 30 minutes. After incubation, 50ul of stop solution is added to each well. A 
slight change in the red colour should happen. Using a pipette tip, any bubbles 
in the wells should be popped. The plate is then measured at 490nm using a 
Multiskan Ascent Platereader (Thermo Electron Corporation). 
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9 Results 
9.1 Analysis of Oxygen Concentration Effects on HIF Dependent 
Transcriptional Responses Over Time 
Previous studies investigating the effects of HIFs within the liver have largely 
focused upon the activities of the HIF1α isoform. These previous studies have 
been conducted using a combination of 20% oxygen representing normoxia and 
1% oxygen to simulate hypoxic conditions. In order to understand the role of 
HIFs within liver disease it is important to understand the kinetics of HIF-
dependent transcriptional responses within the liver. Stroka and colleagues 
data also indicates that the activity of HIFs may be transient. This further 
enhances the importance of studying the kinetics of HIF dependent 
transcriptional activity. It is interesting that HIFs activity is considered transient; 
if this is the case, how are certain cells within the liver that are continually 
exposed to hypoxic conditions regulated. Anatomically the liver exists within an 
oxygen range of 3-11%. Previous data studying HIFs within the liver has 
primarily been conducted at 1% oxygen or less. This oxygen concentration is 
not normally found within the liver environment and therefore there is precedent 
for studying the kinetics of HIF activity under more physiologically relevant 
oxygen concentrations. 3% oxygen is still considered a hypoxic environment 
and some zones within the liver exist near continually at this oxygen 
concentration. Therefore the study of liver cell response to this oxygen 
concentration is justified and a comparison of HRE responses to each oxygen 
concentration was carried out. 
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9.1.1 Exposure to low oxygen levels of oxygen results in increased 
HIF activity over time 
To assess the kinetics of hypoxia driven transcriptional activity we utilised a 
reporter system; HIFs act by binding to HRE regions in the promoters of target 
genes containing the sequence 5’-NCGTG-3’. A HIF promoter driven luciferase 
construct is inserted into the cells and drives expression of luciferase upon HIF 
binding to HRE (Tong et al, 2013). Huh 7.5 cells were transfected with an HRE 
luciferase reporter plasmid. These represent the stabilization of HIFs, 
subsequent dimerization and binding to HRE regions up stream from their 
targets. A luciferase reporter is expressed upon binding to the HRE region. The 
kinetics of HRE activation is indicative of HIF activity within the cells. Figure 6 
represents the initial data generated in this project, indicating that exposure to 
hypoxic levels of oxygen increased HRE-driven luciferase activity over time at 
different oxygen concentrations. There is an increase in activity between 10-15 
hours; this is followed by a decline in activity at both oxygen concentrations 
between 15-25 hours. The literature suggests that after 15 hours the HIF1α 
protein begins to degrade (Uchida et al, 2004). This could be responsible for the 
halt in increased activity. The levels of HRE activity appear comparable 
between different oxygen concentrations. The data generated at each oxygen 
concentration was plotted against normoxic values taken from their respective 
assays. This graph enables clear observation of a pattern in HRE activation that 
is similar at both oxygen concentrations. In summary, these data suggest that 
the exposure to low oxygen is sufficient to stabilize HIFs and to stimulate HRE 
transcriptional activity and luciferase reporter gene expression in Huh-7.5 
  88 
hepatoma cells and that the hypoxic response is similar at both hypoxic 
conditions in Huh 7.5 cells. 
 
Figure 6: HRE luciferase assay showing a comparison of HIF kinetics in 
Huh 7.5 cells exposed to two different hypoxic oxygen concentrations 
Huh 7.5 cells were seeded at 1.5x105 density and transfected with an HRE 
luciferase reporter gene. The cells were then placed into hypoxic or normoxic 
conditions. The data represents the pattern of HRE activation over 25 hours at 
each oxygen condition. The data is plotted as relative fold change in activity 
between hypoxic and normoxic conditions. The graph represents the mean 
values of 3 replicates per time point. A value of P<0.008 was determined at 25 
hours using an unpaired T test with corrections for multiple comparisons. 
 
Following the observations of HRE activation within Huh 7.5 cells we thought it 
would be interesting to compare responses between different cell types in 
addition to different oxygen concentrations. HepG2 cells are a more 
differentiated hepatoma cell line with polarizing capabilities. This experiment 
was performed because the stabilization and activity of HIFs may be different 
within another cell type. Figure 7 represents the transcriptional activation in 
HepG2 cells exposed to hypoxia relative to normoxic control time points. The 
graph indicates an increase in activity over time at both oxygen concentrations. 
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However, the response observed under 3% oxygen appears lower. A different 
profile is evident over 25 hours. Whereas the response under 1% oxygen is 
similar to that observed in Huh 7.5 cells. 
 
Figure 7: HRE luciferase assay showing a comparison of HIF kinetics in 
HepG2 cells exposed to two different hypoxic oxygen concentrations. 
HepG2 cells were seeded at 1.5x105 cells/ml and transfected with an HRE 
luciferase reporter gene. The cells were then placed into hypoxic or normoxic 
conditions. Figure 7 represents the patterns of HRE activation observed at each 
oxygen concentration over 25 hours. The data is plotted relative to normoxic 
controls showing a fold change in activity. HRE response was measured as 
relative light units. The graph represents the mean values of 3 replicates per 
time point. A value of P<0.002 was determined at the 15 hour time point using 
an unpaired T test with corrections for multiple comparisons. 
9.1.2 A comparison of HRE luciferase signals in naïve and highly 
differentiated Huh 7.5 cells 
This experiment was performed in order to study the potential difference in 
response following DMSO mediated differentiation of Huh 7.5 hepatoma cells. 
DMSO treatment arrests cell division and promotes the expression of many 
differentiation markers expressed by primary hepatocytes isolated from human 
liver such as HnF4a (Sainz & Chisari, 2006) or CYP3a4 (Choi et al, 2009). This 
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means that these cells may be a more accurate representation of how the cells 
of a normal healthy liver would respond to hypoxia. Figure 9 shows that highly 
differentiated hepatoma cells induce a lower HRE response compared to 
parental untreated hepatoma cells. 
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Figure 8: HRE luciferase assay showing the effect of hypoxia on HRE 
luciferase signals in DMSO differentiated cells. 
Huh 7.5 cells were seeded at 2x105 cells/ml in 24 well plates and treated with 
DMSO. The cells were left for 7 days to differentiate. Naïve Huh 7.5 cells were 
seeded at 2x105 cells/ml after 7 days. All cells were transfected with an HRE 
luciferase reporter gene. The cells were placed into hypoxic or normoxic 
conditions overnight. A. The raw data comparing the HRE activation observed 
in naïve and highly differentiated Huh 7.5 cells. The graph represents the mean 
values of 3 replicates per time point. A value of P<0.02 was determined using a 
multiple T test. B. The data is plotted relative to normoxic controls showing a 
fold change in activity. The graph represents the mean values of 3 replicates 
per time point. A value of P<0.92 was determined using an unpaired T test. 
HRE response was measured as relative light units. 
 
Figure 8 A indicates that DMSO differentiated cells have a reduced response to 
hypoxic conditions. However, when the data is plotted relative to normoxic 
controls we see very little difference in response between these cells. It is 
important to note that HRE activation appears lower in naïve Huh 7.5 cells 
compared to previous results. 
9.2 Studying the effect of cytokines on HIF activity 
Following initial experiments studying the kinetics of HIF activity and stability, 
we began to investigate the effect of TNFα on HIF transcriptional activity in 
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Huh-7.5 and HepG2 hepatoma cells. Previous studies have shown that 
cytokines such as TH1 cytokine IFN-γ and TH2 cytokine IL-4 stabilize HIFs in 
macrophages (Thieu et al, 2007; Rius et al, 2008). The following experiments 
are performed to test whether the effects of hypoxic conditions and cytokines 
activate HIF differently. Specifically experiments were performed using TNFα, 
which has been reported to stabilize HIF through NFκB (Görlach & Bonello, 
2008). 
These experiments were performed to investigate the effect of treating Huh 7.5 
cells with the pro-inflammatory cytokine TNFα. Previous work has shown that 
the addition of TNFα is capable of stabilizing HIF1α under normoxia and 
hypoxia (Görlach & Bonello, 2008). These experiments aim to study the kinetics 
of this stabilization and to determine whether TNFα may produce an HRE 
response beyond that of hypoxia alone. The data suggests that the addition of 
TNFα does not induce HRE activity beyond that of hypoxia alone. 
To ensure the TNFα used during this experiment is active an assay was 
performed to test TNFα activity by measuring NFκB activation in both Huh 7.5 
and HepG2 cells. Figure 9 B indicates that the addition of TNFα to a sample 
produces a higher luciferase response in cells transfected with an NFκB 
reporter. These are compared to transfected cells treated with media alone. The 
data suggests that the TNFα in use is active and should therefore produce 
expected responses. 
 
 
  93 
 
 
 
 
 
 
 
 
 
 
A 
  94 
 
Figure 9: HRE luciferase assays representing HIF kinetics in Huh 7.5 cells 
following the addition of TNFα. 
(continued next page) 
 
B 
C 
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Figure 9: HRE luciferase assays representing HIF kinetics in Huh 7.5 cells 
following the addition of TNFα (continued). 
Huh 7.5 cells were seeded at 1.5x105 cells/ml and transfected with an HRE 
luciferase reporter gene. Cells were treated with either 100ng of TNFα or with 
untreated media. The samples are then placed under normoxia or 1% oxygen. 
HRE activation is measured in relative light units. A. Figure 9 A represents HRE 
responses under normoxic conditions B. Figure 9 B represents HRE responses 
under 1% oxygen relative to normoxic controls, showing the fold change in 
activation. The graph represents the mean values of 3 replicates per time point. 
A value of P<0.8859 was determined using an unpaired T test. HRE response 
was measured as relative light units. C. Figure 9 C represents HRE activation 
through NFκB stabilization of HIFs in Huh 7.5 cells treated with TNFα compared 
to an untreated control. Huh 7.5 cells were seeded at 1.5x105 cells/ml and 
transfected with an NFκB luciferase reporter gene. The cells were then treated 
with 100ng of TNFα or untreated media. HRE activation is measured in relative 
light units. 
 
Following the investigation into TNFα effects on Huh 7.5 cells, we studied the 
effect on stabilization in HepG2 cells. This experiment was performed because 
the stabilization and activity of HIFs may be different within another cell type. 
These results indicate there is no significant difference in HRE activity in cells 
treated with TNFα beyond that of hypoxic conditions alone. Interestingly there 
may be a blunted response, which may represent negative regulation caused 
by over stimulation. This pattern of activity is consistent with those seen in Huh 
7.5 cells. 
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Figure 10: HRE luciferase assays representing HIF kinetics in HepG2 cells 
following the addition of TNFα. 
(continued next page) 
 
Figure 10: HRE luciferase assays representing HIF kinetics in HepG2 cells 
following the addition of TNFα (continued). 
HepG2 cells were seeded at 1.5x105 cells/ml and transfected with an HRE 
luciferase reporter gene. Cells were treated with either 100ng of TNFα or with 
untreated media. The samples are then placed under normoxia or 1% oxygen. 
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HRE activation is measured in relative light units. A. Figure 10A represents 
HRE responses under normoxic conditions. B. Figure 10 B represents HRE 
responses under 1% oxygen relative to normoxic controls, showing the fold 
change in activation. The graph represents the mean values of 3 replicates per 
time point. A value of P<0.7878 was determined using an unpaired T test. C. 
Figure 10 C represents HRE activation through NFκB stabilization of HIFs in 
HepG2 cells treated with TNFα compared to an untreated control. This data 
shows the activity of TNFα. HRE activation is measured in relative light units. 
9.2.1 Comparison of TNFα effects on DMSO differentiated Huh 7.5 
cells under different oxygen conditions 
This experiment was performed to determine if TNFα produced a difference in 
HRE activation in DMSO differentiated cells. Cells were left to differentiate for 7 
days and were transfected using an HRE luciferase reporter gene plasmid. The 
samples were treated with 100ng of TNFα and placed under hypoxia or 
normoxia overnight. Cells treated with media are used as a control. The data in 
figure 12 indicates no difference in HRE activation between differentiated cells 
that have been treated with TNFα or with media. The result suggests that TNFα 
is not stimulating HIF stabilization within these highly differentiated cells. 
 
Figure 11: The effects of TNFα on HRE luciferase signals in DMSO 
differentiated Huh 7.5 cells 
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Huh 7.5 cells were seeded at 2x105 cells/ml in 24 well plates and treated with 
DMSO. The cells were left for 7 days to differentiate. The cells were transfected 
with an HRE luciferase reporter gene. The cells were placed into hypoxic (1% 
oxygen) or normoxic conditions overnight. HRE activation was measured in 
relative light units. The control cells are untreated DMSO differentiated cells. 
The graph represents the mean values of 3 replicates per time point. A value of 
P<0.11 was determined using an unpaired T test indicating no significant 
difference in activity between control and treated cells. 
 
Following these experiments that showed no significant difference in HRE 
activity upon addition of TNFα while under hypoxia. An HRE luciferase 
experiment was performed to study the effect of Lipopolysaccharide (LPS) 
stimulated macrophage conditioned media on HRE responses. LPS has been 
shown to cause an up-regulation in HIF1α expression in macrophages under 
normoxia (Blouin et al, 2004). LPS stimulates HIF1α stabilization in a TLR4 and 
MyD88 dependent manor. The binding of LPS causes this signalling cascade to 
TLR4. The pathway may involve a number of different factors including reactive 
oxygen species, inhibition of PHDs and MAPK or NFκB signalling (Imtiyaz & 
Simon, 2010). This experiment was performed to test the kinetics of HRE 
transcriptional activity in HepG2 cells in response to the conditioned media 
collected from LPS stimulated macrophages. Macrophages were stimulated 
with increasing concentrations of LPS (0.1, 1 and 10ug/ml) and incubated 
overnight and the conditioned media harvested and used to treat HepG2 cells 
transfected with HRE under normoxia or hypoxia. As a control, conditioned 
media from un-stimulated macrophages was used. The data suggests that LPS 
conditioned media activated HRE-Luc under both hypoxia and normoxia. 
Coupled with previous results showing that TNFa stimulates no additional 
response; this suggests that there may be additional cytokines or activating 
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factors within LPS conditioned media that induce HIF stabilization. Garrick 
Wilson, who has kindly allowed the use of this data, performed this experiment. 
 
Figure 12: A dose response representing HRE activation after treatments 
with lipopolysaccharide stimulate macrophage-conditioned media. 
HepG2 cells were seeded at 1.5x105 cells/ml and transfected with an HRE 
luciferase reporter gene. The cells treated with increasing concentrations of 
LPS and left overnight. Untreated and un-stimulated cell conditioned media are 
used as controls in this experiment. The samples are placed under hypoxia or 
normoxia. Relative light units represent HRE activation. An HRE response is 
observed under both hypoxia and normoxia. Each point represents the relative 
fold increase in activity compared to untreated controls. Each point shows the 
mean value of 3 replicates. A value of P<0.0001 was obtained at LPS 0.1. 
P<0.005 for LPS 1 and P<0.002 for LPS 10 using a multiple T test. 
 
9.3 Chronic exposure to hypoxia 
The majority of experiments conducted studying the effects of hypoxia in the 
liver have been under normoxia or acute hypoxia. Acute hypoxia is between 0-
24 hours. Chronic hypoxia is exposure to low oxygen conditions beyond 24 
hours (Lin et al, 2011). It has been shown that exposure to chronic hypoxic 
conditions can alter cell morphology, proliferation, biomarkers and protein 
expression with in some cell types (Zhdanov et al, 2013). It would be interesting 
to study this within hepatocytes; of which some may be exposed to hypoxic 
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conditions regularly. Zhdanov and colleagues also suggest that the exposure to 
chronic hypoxia can alter the regulation of HIFs; specifically they suggest that 
chronic exposure will result in reduced HIF2a activity. Therefore it was decided 
that an experiment studying the effects of chronic exposure on HIF activity and 
stabilization would be performed. Previous data (figure 7B and 8B) suggests 
that the signal begins to decline after 15 hours of exposure to hypoxic 
conditions. It would be interesting to establish kinetics at later time points to 
determine if this transient activation of stress response genes becomes 
reactivated after time. 
This experiment was performed to determine if there is a difference in HRE 
activation between parental and DMSO differentiated Huh-7.5 cells after chronic 
exposure to hypoxic conditions. The data suggests that after 24 hours there is 
HRE activation, with the levels of activation comparable to previous assays in 
all conditions. The results indicate a fold change in activity compared to 
normoxic controls. Naïve Huh 7.5 cells exposed to hypoxic conditions for 36 
hours produced a significantly higher HRE response compared to previous 
assay. There is approximately a 10-fold difference in activation between the 24 
and 36-hour time points. Comparatively, the DMSO differentiated cells 
produced no reactivation in HRE response after 36 hours. This suggests a 
difference in how HIF activity is regulated between naïve hepatoma cells and 
highly differentiated cells. 
  101 
 
Figure 13: A time course of HRE activation over chronic exposure to 
hypoxic conditions. 
Huh 7.5 cells were seeded at 2x105 cells/ml in 24 well plates and treated with 
DMSO. The cells were left for 7 days to differentiate. Naïve Huh 7.5 cells were 
seeded at 2x105 cells/ml after 7 days. All cells were transfected with an HRE 
luciferase reporter gene. The cells were placed into hypoxic or normoxic 
conditions over 36 hours. The data is plotted relative to normoxic controls; each 
time point represents the mean values of 3 replicates. A value of P<0.197 was 
obtained at 24 hours using a multiple row T test indicating no significant 
difference in activity at this time. A value of P<0.016 was determined at 36 
hours using a multiple row T test indicating a significant difference in activity 
between naïve and differentiated cells. 
 
Following experimentation with parental and DMSO differentiated cells over 
chronic exposure to hypoxic conditions, it is important to determine the viability 
of cells. To assess cell viability we measured cell membrane integrity through 
the presence of lactate dehydrogenase. Cell supernatants were collected from 
cells exposed to chronic hypoxic conditions (see section 1.3). A total cell lysis 
control obtained through freeze-thaw lysis of each sample was used for 
comparison with supernatants. The values obtained from cell lysis controls 
represent 100% cell death. The respective supernatants for each sample are 
then measured and the result shown as a percentage of cell death compared to 
the control (Figure 14). 
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Figure 14: An LDH assay comparing cell viability of naïve and highly 
differentiated Huh 7.5 cells exposed to hypoxia or normoxia over time. 
Huh 7.5 cells were seeded at 2x105 cells/ml in 24 well plates and treated with 
DMSO. The cells were left for 7 days to differentiate. Naïve Huh 7.5 cells were 
seeded at 2x105 cells/ml after 7 days. The cells were transfected with an HRE 
luciferase reporter. Samples were placed into hypoxia or normoxia. Following 
incubation cell supernatants were removed from each time point. A total lysis 
control of each sample was obtained through freeze thaw lysis. Figure 14 
represents an LDH assay comparing cell viability in both naïve and highly 
differentiated Huh 7.5 cells exposed to hypoxic conditions over 36 hours. Each 
bar represents the mean values of 3 replicates. 
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10 Discussion 
Ultimately the purpose of the investigation was to study the hypoxia inducible 
factors and their effects within HCV biology and liver injury. In particular, this 
project focused on the kinetics involved in HIF-dependent transcriptional 
activity. This project is part of a larger on going study into HCV and hypoxia. 
The results generated during this project provide good preliminary data for a 
larger study into HIFs and HCV. The HIF1α pathways have been thoroughly 
studied in the past under normoxic conditions and more recently under hypoxia 
in the liver. However, this project focuses on the kinetics of HIF activity and 
stabilisation under both oxygen conditions in two independent hepatoma cell 
lines. Based upon the results obtained throughout the course of this project we 
can draw some conclusions with regards to HIF-dependent transcriptional 
activity. 
Firstly, these data suggest that the exposure to low oxygen is sufficient to 
stabilise HIFs and to stimulate HRE transcriptional activity and luciferase 
reporter gene expression in Huh-7.5 hepatoma cells (Figure 6). A similar pattern 
in HRE activation is observed in HepG2 cells exposed to low oxygen. Both cell 
lines when placed under 1% oxygen produce HRE activity 20-fold higher than 
those under normoxic conditions (Figure 7). The results indicate a difference in 
activity in cells exposed to 3% oxygen. A faster decline in activity is observed in 
Huh 7.5 cells exposed to 3% oxygen compared to 1% oxygen; this difference 
was significant with a value of P<0.008 (Figure 6). Uchida and colleagues 
describe an antisense HIF1α (aHIF) transcript, which accumulates over time 
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under hypoxia and is involved in regulation of HIFs by inhibiting activity; 
perhaps this is involved in the decline in activity seen after 15 hours. It is also 
suggested that accumulation of this transcript destabilises HIFα subunit mRNA 
(Uchida et al, 2004). Figure 7 indicates a difference in activity between 1% and 
3% oxygen in HepG2 cells; a 4-fold difference in activity can be observed at the 
point of highest activity with a value of P<0.002 obtained here. Holmquist-
Mengelbier and colleagues show that varying oxygen concentrations can 
determine which HIFα subunit is expressed in neuroblastoma cells. The 
difference in activity observed within these cells (Figure 7) could be due to the 
differential expression of these transcription factors. The same effect has been 
in observed in HeLa, glioma and lung epithelial cells (Uchida et al, 2004; 
Nilsson et al, 2005; Li et al, 2009, Keith et al, 2012). These papers suggest that 
HIF1α is expressed between 0-2% oxygen and HIF2α is expressed between 2-
5% oxygen. Following these experiments, assays were conducted to observe 
the effect of low oxygen on highly DMSO differentiated Huh 7.5 cells. These 
data initially indicated reduced activity within DMSO treated cells (Figure 8A). 
However, when plotted relative to normoxic controls the fold change in activity 
compared to controls shows no significant difference (Figure 8B). Also, it is 
important to note that the relative fold change in activity observed within naïve 
Huh 7.5 cells is significantly lower than observed in previous experiments. This 
suggests it may be necessary to repeat the assay to confirm the results 
observed in DMSO treated cells. Experiments were then performed to study the 
effect of pro-inflammatory cytokines on HIF-dependent transcriptional activity. 
These have been shown to induce transcriptional activity in a number of cells 
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types under normoxia previously in an NFκB dependent manor (Frede et al, 
2005; Bonello et al, 2007; Jiang et al, 2010). Assays using both Huh 7.5 and 
HepG2 cells indicate no significant difference in activity between cells exposed 
to low oxygen over 25 hours and the same cells exposed to low oxygen and 
treated with TNFα (Figures 9A and 10A). This data is plotted relative to 
normoxic controls and shows TNFα cannot induce an HRE response beyond 
that of hypoxia alone. Both figures indicate that there may be a lower HIF 
dependent transcriptional activation under hypoxia in cells treated with TNFα; 
however statistical analyses indicate no significant difference. Tsapournioti and 
colleagues (2013) have shown that TNFα induces expression of HIF1α mRNA 
and proteins in an NFκB dependent manor. However, they also show that TNFα 
inhibits the hypoxic stimulation of HIF1 dependent transcriptional activity in 
Airway Smooth Muscle Cells (ASMCs). They show this inhibition occurs by 
preventing dimerization of HIF1α with HIFB. Could the lack of additional activity 
and slight decrease observed in these hepatoma cell lines be due to similar 
TNFα activity? 
Figure 12 represents results of an HRE luciferase assay studying HRE 
response to increasing concentrations of LPS stimulated macrophage 
conditioned media. Under hypoxic conditions the graph indicates an increase in 
activity with increasing concentrations. This data coupled with previous results 
showing TNFα produces no response beyond hypoxia alone suggests there 
may be another cytokine or factor present within LPS conditioned media 
responsible for activating the HRE response. Statistical analyses show a 
significant difference in activity with values of P<0.0001, P<0.005 and P<0.002 
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for concentrations LPS 0.1, 1.0 and 10 respectively between treated and 
untreated cells. 
Figure 13 represents an HRE luciferase time course assay investigating HIF-
dependent transcriptional activity within naïve and highly DMSO differentiated 
Huh 7.5 cells exposed to chronic hypoxia. This data indicates that chronic 
exposure to hypoxia (24<hours) results in activation of HIFs significantly higher 
than observed at 24 hours or earlier with approximately 10-fold difference in 
activation observable in figure 13. Indeed, results in figures 6 and 7 indicate that 
activity decreases after 15 hours. However, it has been shown that chronic 
exposure to low oxygen can alter cell morphology, protein expression and 
proliferation (Lin et al, 2011; Zhdanov et al, 2013). They also suggest that HIFs 
may be regulated differently during chronic exposure via different signalling 
pathways. An LDH assay was performed to check the cell viability; this was 
used to confirm that the cells exposed to low oxygen for more than 24 hours 
had not simply died. 
The data generated throughout this project was largely gathered using an HRE 
luciferase reporter gene. Due to the nature of the assay, the experiment could 
be adapted to study a number of aspects in the HIF pathway. The literature 
shows that most experiments studying HIF activity within the liver are conducted 
using either normoxic conditions with 20% oxygen or hypoxic conditions of 1% 
oxygen or less. Neither of these conditions is found within the liver, which 
normally exists between 3-11% oxygen (Figure 1). Consequently, we conducted 
assays to compare the difference in HIF stabilisation and activity between 
previously used 1% oxygen and the more anatomically correct 3% oxygen. The 
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results shown in figures 6 and 7 indicate that there is minimal difference in HIF 
stabilisation between these hypoxic conditions and suggests that the use of 1% 
oxygen will produce accurate results in additional experiments. However, some 
previous papers suggest that the level of oxygen is important in determining 
which HIFs become stabilised (Uchida et al, 2004; Nilsson et al, 2005; Li et al, 
2009). They suggest that between 0-2% oxygen HIF1α is stabilised and that 
between 2-5% oxygen, HIF2α become stabilised. This suggests that the 
kinetics displayed at 3% oxygen might represent those of HIF2α. If this is the 
case then the kinetics displayed by both HIFs are very similar suggesting similar 
methods of regulation. To this effect it is important to establish the transcription 
factor being studies using Western Blotting; however to date these experiments 
have been unsuccessful, perhaps due to the instability of HIFs when removed 
from hypoxic conditions. It has been shown that DMSO differentiated Huh 7.5 
cells express a number of biomarkers similar to those of primary human 
hepatocytes (Sainz & Chisari, 2006) and stop dividing like cells within the liver. 
These therefore provide an interesting basis for studying the kinetics of HIF 
activity in cells similar to PHH cells. 
The most widely used assay was the HRE luciferase reporter gene assay to 
study HIF kinetics in a couple of different cell types exposed to different levels 
of oxygen and cytokine treatments. This assay has a number of strengths and 
weaknesses that should be discussed. In an attempt to optimize this assay in 
future and hopefully produce cleaner results, the seeding of cells and 
transfections will now occur on the same day. Splitting into 96 well plates must 
still occur on day 2 however. Another limitation of this technique is that it does 
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not allow for distinction between the isoform of HIF responsible for the HRE 
response. This is particularly important because there is literature, which 
suggests that different isoforms of HIFs are expressed under different oxygen 
concentrations. The assay is versatile, which enables the study of multiple 
facets of HIF kinetics in liver cells. 
Following these results it would be interesting to run a similar assay at higher 
oxygen concentrations representative of other regions in the liver to determine if 
any HRE signals are visible. Previous experiments studying the effects of HIF1α 
have also been conducted using 5% and 10% oxygen. This would be 
interesting as a comparison to the patterns after exposure to low oxygen levels 
observed already. Also, while a minimal or non-existent signal might be 
expected because HIFs are not stabilised under higher oxygen concentrations; 
it would be interesting to see the effect of cytokines that may stabilise HIFs over 
the same time course. Additionally, the production of a successful HIF1α or 
HIF2α Western Blot is essential for continued study in this area. These would 
show the protein expression and enable the study of HIF1α or HIF2α kinetics 
after silencing the other. It would be particularly interesting to study the 
endogenous HIF protein levels found within these cell lines under varying 
oxygen tensions. Other studies have suggested that upon the silencing of one, 
the other becomes over expressed (Schulz et al, 2012). The silencing of one 
subunit could cause the up regulation of the other as a compensation 
mechanism. It has been shown previously that within kidney cells there is 
overlap in the targets of each subunit (Majmundar et al, 2010. Keith et al, 2012. 
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Schulz et al, 2012). It would be interesting to determine how many genes 
overlap between each subunit in hepatocytes. 
Further study into the effects of chronic exposure to low oxygen would also be 
really interesting. The data generated throughout this project shows that the 
HRE signal starts to decline after 15 hours, this is in keeping with the literature, 
which suggests that the protein starts to degrade after this time. However, it 
would be interesting to know whether these responses are reactivated after 
longer exposure to hypoxia. In addition, it would be interesting to establish 
whether a specific isoform is responsible for activation beyond 24 hours; it has 
been suggested that HIF2α activity is reduced after chronic exposure to low 
oxygen (Zhdanov et al, 2013). 
Based on the results obtained during this project and the objectives outlined at 
the beginning there are a number of points that would be interesting to study. 
HIF2α is the immediate target for study; it would be interesting to know how the 
kinetics differs from HIF1α. This will require targeted silencing of both HIF 
isoforms and the use of both HRE luciferase reporter assays and Western 
blotting. Is expression of a specific subunit linked to oxygen concentration in the 
liver? Does HIF2α respond to different cytokines in hepatocytes? Does HIF2α 
dependent transcriptional activation work through the same signalling pathways 
(NFκB, TNF receptors etc). HIF3α is also apparently stabilised under low 
oxygen. Does this apply in the liver? Does it regulate stress responses like 1α 
and 2α? Or does it just regulate 1α and 2α? This could be studied through the 
use of co-localisation studies and dual reporter assays. 
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The experiments performed as part of this project may help in the future 
development of treatments for HCV and other members of the flavivirus family. 
They provide the groundwork for a larger study into HIF physiology and 
pathobiology in the liver with a range of oxygen tensions. This work is important 
because it touches upon the role that HIFs might play in regulating different 
metabolic processes under different prevailing oxygen tensions in certain 
regions of the liver. In addition studying the hepatocyte responses to hypoxia, 
the stability and activity of HIFs may lead to a better understanding of the 
normal host response to hypoxia in the liver and give greater insight into how 
HCV can utilize this stress response to aid in its viral lifecycle. 
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